BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215-23. [PMID: 16983741 DOI: 10.1002/bjs.5506] [Cited by in Crossref: 799] [Cited by in F6Publishing: 629] [Article Influence: 53.3] [Reference Citation Analysis]
Number Citing Articles
1 Moureau-zabotto L, Resbeut M, Gal J, Mineur L, Teissier E, Hebuterne X, Muyldermans P, Francois E, Chamorey E, Gerard J. Management and clinical outcome of rectal cancer in patients ≥80 years treated in southern France (PACA region) between 2006 and 2008: Treatment of Rectal Cancer in Elderly Patients. J Surg Oncol 2013;108:450-6. [DOI: 10.1002/jso.23428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Scott NA, Susnerwala S, Gollins S, Sun Myint A, Levine E. Preoperative neo-adjuvant therapy for curable rectal cancer - reaching a consensus 2008. Colorectal Disease 2009;11:245-8. [DOI: 10.1111/j.1463-1318.2008.01636.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
3 Roselló S, Papaccio F, Roda D, Tarazona N, Cervantes A. The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision. Cancer Treat Rev 2018;63:156-71. [PMID: 29407455 DOI: 10.1016/j.ctrv.2018.01.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
4 Jianyang W, Yuan T, Yuan T, Xin W, Ning L, Hua R, Hui F, Yanru F, Shulian W, Yongwen S, Yueping L, Weihu W, Yexiong L, Jing J. A prospective phase II study of magnetic resonance imaging guided hematopoietical bone marrow-sparing intensity-modulated radiotherapy with concurrent chemotherapy for rectal cancer. Radiol Med 2016;121:308-14. [PMID: 26612321 DOI: 10.1007/s11547-015-0605-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 Lutz MP, Zalcberg JR, Glynne-Jones R, Ruers T, Ducreux M, Arnold D, Aust D, Brown G, Bujko K, Cunningham C. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. Eur J Cancer. 2016;63:11-24. [PMID: 27254838 DOI: 10.1016/j.ejca.2016.04.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 11.2] [Reference Citation Analysis]
6 Mendenhall WM, Zlotecki RA, Snead FE, George TJ Jr, Marsh RD, Mendenhall CM, Rout WR. Radiotherapy in the treatment of resectable rectal adenocarcinoma. Am J Clin Oncol 2009;32:629-38. [PMID: 19593081 DOI: 10.1097/COC.0b013e31817ff8e4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Latkauskas T, Pauzas H, Kairevice L, Petrauskas A, Saladzinskas Z, Janciauskiene R, Gudaityte J, Lizdenis P, Svagzdys S, Tamelis A, Pavalkis D. Preoperative conventional chemoradiotherapy vs short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial. BMC Cancer. 2016;16:927. [PMID: 27903247 DOI: 10.1186/s12885-016-2959-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
8 何振华, 张森. 结直肠癌NCCN、NICE指南及中国卫生部诊疗规范的比较. 世界华人消化杂志 2013; 21(14): 1297-1302 [DOI: 10.11569/wcjd.v21.i14.1297] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Sato H, Maeda K, Maruta M. Prognostic significance of lateral lymph node dissection in node positive low rectal carcinoma. Int J Colorectal Dis 2011;26:881-9. [DOI: 10.1007/s00384-011-1170-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
10 Park YY, Lee KY, Kim NK, Lee SB, Kim GR, Min BS, Oh ST. Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients. Ann Coloproctol 2019;35:335-41. [PMID: 31937073 DOI: 10.3393/ac.2019.03.10] [Reference Citation Analysis]
11 Dutta SW, Alonso CE, Jones TC, Waddle MR, Janowski EM, Trifiletti DM. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database. Clin Colorectal Cancer 2018;17:297-306. [PMID: 30146228 DOI: 10.1016/j.clcc.2018.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Faria S, Kopek N, Hijal T, Liberman S, Charlebois P, Stein B, Meterissian S, Meguerditchian A, Fawaz Z, Artho G. Phase II trial of short-course radiotherapy followed by delayed surgery for locoregionally advanced rectal cancer. Colorectal Dis. 2014;16:O66-O70. [PMID: 24148225 DOI: 10.1111/codi.12466] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
13 Yu M, Lee JH, Jang HS, Jeon DM, Cheon JS, Lee HC, Lee JH. A comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancer. Radiat Oncol 2013;8:181. [PMID: 23866263 DOI: 10.1186/1748-717X-8-181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Kennedy E, Vella ET, Blair Macdonald D, Wong CS, McLeod R; Cancer Care Ontario Preoperative Assessment for Rectal Cancer Guideline Development Group. Optimisation of preoperative assessment in patients diagnosed with rectal cancer. Clin Oncol (R Coll Radiol). 2015;27:225-245. [PMID: 25656631 DOI: 10.1016/j.clon.2015.01.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
15 Verma K, Engineer R, Ostwal V, Kumar S, Arya S, Desouza AL, Saklani AP. Persistent involvement of anterior mesorectal fascia in carcinoma rectum - extended resection of rectum vs total pelvic exenteration: results from a single-centre retrospective study. Colorectal Dis 2018;20:1070-7. [PMID: 29985547 DOI: 10.1111/codi.14336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yang Y, Liu Q, Jia B, Du X, Dai G, Liu H, Chen J, Zeng M, Wen K, Zhu Y, Wang Y, Feng L. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer. Technol Cancer Res Treat 2019;18:153303381882436. [DOI: 10.1177/1533033818824367] [Reference Citation Analysis]
17 Scheer AS, Boushey RP, Liang S, Doucette S, O'Connor AM, Moher D. The long-term gastrointestinal functional outcomes following curative anterior resection in adults with rectal cancer: a systematic review and meta-analysis. Dis Colon Rectum 2011;54:1589-97. [PMID: 22067190 DOI: 10.1097/DCR.0b013e3182214f11] [Cited by in Crossref: 60] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
18 Rahbari NN, Elbers H, Askoxylakis V, Motschall E, Bork U, Büchler MW, Weitz J, Koch M. Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials. Ann Surg Oncol. 2013;20:4169-4182. [PMID: 24002536 DOI: 10.1245/s10434-013-3198-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
19 Krishnamurthi SS, Seo Y, Kinsella TJ. Adjuvant therapy for rectal cancer. Clin Colon Rectal Surg 2007;20:167-81. [PMID: 20011198 DOI: 10.1055/s-2007-984861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
20 Theis V, Sripadam R, Ramani V, Lal S. Chronic Radiation Enteritis. Clinical Oncology 2010;22:70-83. [DOI: 10.1016/j.clon.2009.10.003] [Cited by in Crossref: 151] [Cited by in F6Publishing: 116] [Article Influence: 13.7] [Reference Citation Analysis]
21 Ferrari L, Fichera A. Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer.Gastroenterol Rep (Oxf). 2015;3:277-288. [PMID: 26290512 DOI: 10.1093/gastro/gov039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
22 Ansari N, Young CJ, Schlub TE, Dhillon HM, Solomon MJ. Understanding surgeon decision making in the use of radiotherapy as neoadjuvant treatment in rectal cancer. International Journal of Surgery 2015;24:1-6. [DOI: 10.1016/j.ijsu.2015.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Mccarthy K, Pearson K, Fulton R, Hewitt J; Cochrane Colorectal Cancer Group. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd008368.pub2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 52] [Article Influence: 3.0] [Reference Citation Analysis]
24 Ishihara S, Watanabe T, Akahane T, Shimada R, Horiuchi A, Shibuya H, Hayama T, Yamada H, Nozawa K, Igaki H, Matsuda K. Prognostic significance of adverse events associated with preoperative radiotherapy for rectal cancer. Int J Colorectal Dis 2011;26:911-7. [DOI: 10.1007/s00384-011-1156-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
25 Siegel R, Dresel S, Koswig S, Gebauer B, Hünerbein M, Schneider W, Schlag PM. Response to Preoperative Short-Course Radiotherapy in Locally Advanced Rectal Cancer: Value of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography. Onkologie 2008;31:166-72. [DOI: 10.1159/000118037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
26 Rasulov AO, Gordeyev SS, Barsukov YA, Tkachev SI, Malikhov AG, Balyasnikova SS, Fedyanin MY. Short-course preoperative radiotherapy combined with chemotherapy, delayed surgery and local hyperthermia for rectal cancer: a phase II study. International Journal of Hyperthermia 2016;33:465-70. [DOI: 10.1080/02656736.2016.1272138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
27 Glynne-Jones R, Hadaki M, Harrison M. The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers. J Gastrointest Oncol 2013;4:264-84. [PMID: 23997939 DOI: 10.3978/j.issn.2078-6891.2013.037] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
28 Sterzing F, Hoehle F, Ulrich A, Jensen A, Debus J, Muenter M. Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients. J Radiat Res 2015;56:169-76. [PMID: 25341424 DOI: 10.1093/jrr/rru089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
29 Fok M, Toh S, Easow J, Fowler H, Clifford R, Parsons J, Vimalachandran D. Proton beam therapy in rectal cancer: A systematic review and meta-analysis. Surg Oncol 2021;38:101638. [PMID: 34340196 DOI: 10.1016/j.suronc.2021.101638] [Reference Citation Analysis]
30 Guo S, Reddy CA, Kolar M, Woody N, Mahadevan A, Deibel FC, Dietz DW, Remzi FH, Suh JH. Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience. Radiat Oncol. 2012;7:110. [PMID: 22817880 DOI: 10.1186/1748-717x-7-110] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
31 Cambray M, González-Viguera J, Macià M, Losa F, Soler G, Frago R, Mullerat JM, Castellví J, Guinó E. Short-course radiotherapy in stage IV rectal cancer with resectable disease. Clin Transl Oncol 2021. [PMID: 34081292 DOI: 10.1007/s12094-021-02647-0] [Reference Citation Analysis]
32 van Gijn W, van Stiphout R, van de Velde C, Valentini V, Lammering G, Gambacorta M, Påhlman L, Bujko K, Lambin P. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy. Annals of Oncology 2015;26:928-35. [DOI: 10.1093/annonc/mdv023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
33 Ayala DN, Russo SM, Blackstock AW. Multidisciplinary treatment of resectable rectal cancer. Expert Rev Gastroenterol Hepatol 2009;3:383-94. [PMID: 19673625 DOI: 10.1586/egh.09.33] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Bujko K. Timing of surgery following preoperative therapy in rectal cancer: there is no need for a prospective randomized trial. Dis Colon Rectum. 2012;55:e31; author reply e31-e32. [PMID: 22469807 DOI: 10.1097/dcr.0b013e31823f86cb] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
35 Kulu Y, Hackert T, Debus J, Weber MA, Büchler MW, Ulrich A. [Role of neoadjuvant radiotherapy for rectal cancer : Is MRI-based selection a future model?]. Chirurg 2016;87:573-8. [PMID: 27339645 DOI: 10.1007/s00104-016-0236-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
36 Pfeiffer P, Gruenberger T, Glynne-Jones R. Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first? Ther Adv Med Oncol 2018;10:1758835918787993. [PMID: 30093921 DOI: 10.1177/1758835918787993] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
37 Pettersson D, Lörinc E, Holm T, Iversen H, Cedermark B, Glimelius B, Martling A. Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg. 2015;102:972-978; discussion 978. [PMID: 26095256 DOI: 10.1002/bjs.9811] [Cited by in Crossref: 120] [Cited by in F6Publishing: 97] [Article Influence: 20.0] [Reference Citation Analysis]
38 Jensen G, Tao R, Eng C, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Koay E, Taniguchi C, Krishnan S, Das P. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation. Adv Radiat Oncol 2018;3:595-600. [PMID: 30370360 DOI: 10.1016/j.adro.2018.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Bujko K. Short-course preoperative radiotherapy for low rectal cancer. J Clin Oncol 2013;31:1799. [PMID: 23547083 DOI: 10.1200/JCO.2012.47.3769] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Habr-gama A, Perez RO, Lynn PB, São Julião GP, Gama Rodrigues JJ. Selective non-operative management of distal rectal cancer: The Watch & Wait Protocol. In: Schiessel R, Metzger P, editors. Intersphincteric Resection for Low Rectal Tumors. Vienna: Springer; 2012. pp. 43-53. [DOI: 10.1007/978-3-7091-0929-8_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Dewdney A, Cunningham D. Toward the non-surgical management of locally advanced rectal cancer. Curr Oncol Rep 2012;14:267-76. [PMID: 22460631 DOI: 10.1007/s11912-012-0234-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
42 Koseła-Paterczyk H, Szacht M, Morysiński T, Ługowska I, Dziewirski W, Falkowski S, Zdzienicki M, Pieńkowski A, Szamotulska K, Switaj T, Rutkowski P. Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas. Eur J Surg Oncol 2014;40:1641-7. [PMID: 25282099 DOI: 10.1016/j.ejso.2014.05.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
43 Nishimura J, Hasegawa J, Kato T, Yoshioka S, Noura S, Kagawa Y, Yasui M, Ikenaga M, Murata K, Hata T, Matsuda C, Mizushima T, Yamamoto H, Doki Y, Mori M; Clinical Study Group of Osaka University (CSGO) Colorectal Group. Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer. Cancer Chemother Pharmacol 2018;82:707-16. [PMID: 30078098 DOI: 10.1007/s00280-018-3663-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
44 Nacion AJD, Park YY, Kim NK. Contemporary management of locally advanced rectal cancer: Resolving issues, controversies and shifting paradigms. Chin J Cancer Res 2018;30:131-46. [PMID: 29545727 DOI: 10.21147/j.issn.1000-9604.2018.01.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
45 Banwell VC, Phillips HA, Duff MJ, Speake D, Mclean C, Williams LJ, He Y, Paterson HM. Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer. Acta Oncologica 2019;58:1267-72. [DOI: 10.1080/0284186x.2019.1631473] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Lee JH, Chie EK, Kim K, Jeong SY, Park KJ, Park JG, Kang GH, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW. The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer. BMC Cancer 2013;13:576. [PMID: 24304825 DOI: 10.1186/1471-2407-13-576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
47 Qin Q, Ma T, Deng Y, Zheng J, Zhou Z, Wang H, Wang L, Wang J. Impact of Preoperative Radiotherapy on Anastomotic Leakage and Stenosis After Rectal Cancer Resection: Post Hoc Analysis of a Randomized Controlled Trial. Diseases of the Colon & Rectum 2016;59:934-42. [DOI: 10.1097/dcr.0000000000000665] [Cited by in Crossref: 42] [Cited by in F6Publishing: 21] [Article Influence: 8.4] [Reference Citation Analysis]
48 Schrag D. Evolving role of neoadjuvant therapy in rectal cancer. Curr Treat Options Oncol 2013;14:350-64. [PMID: 23828092 DOI: 10.1007/s11864-013-0242-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
49 Chua TC, Morris DL. Therapeutic potential of surgery for metastatic colorectal cancer. Scandinavian Journal of Gastroenterology 2011;47:258-68. [DOI: 10.3109/00365521.2012.640823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Glynne-jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2017;28:iv22-40. [DOI: 10.1093/annonc/mdx224] [Reference Citation Analysis]
51 Boland PM, Fakih M. The emerging role of neoadjuvant chemotherapy for rectal cancer. J Gastrointest Oncol. 2014;5:362-373. [PMID: 25276409 DOI: 10.3978/j.issn.2078-6891.2014.060] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
52 Park HC, Choi DH. Radiation Therapy for Colorectal Cancer. J Korean Med Assoc 2010;53:592. [DOI: 10.5124/jkma.2010.53.7.592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Dumont F, Mariani A, Elias D, Goéré D. Surgical strategy for low rectal cancers. J Visc Surg 2015;152:23-31. [PMID: 25455959 DOI: 10.1016/j.jviscsurg.2014.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
54 Yoon MS, Nam T, Kim H, Nah B, Chung W, Kim Y, Ahn S, Song J, Jeong J. Results of Preoperative Concurrent Chemoradiotherapy for the Treatment of Rectal Cancer. J Korean Soc Ther Radiol Oncol 2008;26:247. [DOI: 10.3857/jkstro.2008.26.4.247] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 McDonald F, Waters R, Gulliford S, Hall E, James N, Huddart RA. Defining bowel dose volume constraints for bladder radiotherapy treatment planning. Clin Oncol (R Coll Radiol) 2015;27:22-9. [PMID: 25445550 DOI: 10.1016/j.clon.2014.09.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
56 Gomez-Millan J. Radiation therapy in the elderly: more side effects and complications? Crit Rev Oncol Hematol 2009;71:70-8. [PMID: 19144538 DOI: 10.1016/j.critrevonc.2008.11.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
57 Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490-1502. [PMID: 24225001 DOI: 10.1016/s0140-6736(13)61649-9] [Cited by in Crossref: 1517] [Cited by in F6Publishing: 962] [Article Influence: 189.6] [Reference Citation Analysis]
58 Adamina M, Gié O, Demartines N, Ris F. Contemporary perioperative care strategies. British Journal of Surgery 2013;100:38-54. [DOI: 10.1002/bjs.8990] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
59 Margalit DN, Mamon HJ, Ancukiewicz M, Kobayashi W, Ryan DP, Blaszkowsky LS, Clark J, Willett CG, Hong TS. Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older. Int J Radiat Oncol Biol Phys. 2011;81:e735-e741. [PMID: 21377289 DOI: 10.1016/j.ijrobp.2010.12.056] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
60 Aklilu M, Eng C. The current landscape of locally advanced rectal cancer. Nat Rev Clin Oncol. 2011;8:649-659. [PMID: 21826084 DOI: 10.1038/nrclinonc.2011.118] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
61 Glimelius B, Påhlman L, Cervantes A; ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21 Suppl 5:v82-6. [PMID: 20555109 DOI: 10.1093/annonc/mdq170] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 6.5] [Reference Citation Analysis]
62 Bębenek M. Abdominosacral resection is not related to the risk of neurological complications in patients with low-rectal cancer. Colorectal Disease 2009;11:373-6. [DOI: 10.1111/j.1463-1318.2008.01630.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
63 Kennedy ED, Simunovic M, Jhaveri K, Kirsch R, Brierley J, Drolet S, Brown C, Vos PM, Xiong W, MacLean T, Kanthan S, Stotland P, Raphael S, Chow G, O'Brien CA, Cho C, Streutker C, Wong R, Schmocker S, Liberman S, Reinhold C, Kopek N, Marcus V, Bouchard A, Lavoie C, Morin S, Périgny M, Wright A, Neumann K, Clarke S, Patil NG, Arnason T, Williams L, McLeod R, Brown G, Mathieson A, Pooni A, Baxter NN. Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial. JAMA Oncol 2019;5:961-6. [PMID: 30973610 DOI: 10.1001/jamaoncol.2019.0186] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 27.0] [Reference Citation Analysis]
64 Pietrzak L, Bujko K, Nowacki MP, Kepka L, Oledzki J, Rutkowski A, Szmeja J, Kladny J, Dymecki D, Wieczorek A. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol. 2007;84:217-225. [PMID: 17692977 DOI: 10.1016/j.radonc.2007.07.007] [Cited by in Crossref: 122] [Cited by in F6Publishing: 101] [Article Influence: 8.7] [Reference Citation Analysis]
65 Nagtegaal ID, Marijnen CAM. The future of TNM staging in rectal cancer: The era of neoadjuvant therapy. Curr colorectal cancer rep 2008;4:147-54. [DOI: 10.1007/s11888-008-0024-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
66 Artac M, Korkmaz L, El-Rayes B, Philip PA. An update on the multimodality of localized rectal cancer. Crit Rev Oncol Hematol 2016;108:23-32. [PMID: 27931837 DOI: 10.1016/j.critrevonc.2016.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
67 González-Flores E, Losa F, Pericay C, Polo E, Roselló S, Safont MJ, Vera R, Aparicio J, Cano MT, Fernández-Martos C. SEOM Clinical Guideline of localized rectal cancer (2016). Clin Transl Oncol 2016;18:1163-71. [PMID: 27905053 DOI: 10.1007/s12094-016-1591-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
68 Akgun E, Caliskan C, Bozbiyik O, Yoldas T, Sezak M, Ozkok S, Kose T, Karabulut B, Harman M, Ozutemiz O. Randomized clinical trial of short or long interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2018;105:1417-1425. [PMID: 30155949 DOI: 10.1002/bjs.10984] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
69 Cerezo L, Ciria JP, Arbea L, Liñán O, Cafiero S, Valentini V, Cellini F. Current treatment of rectal cancer adapted to the individual patient. Rep Pract Oncol Radiother 2013;18:353-62. [PMID: 24416579 DOI: 10.1016/j.rpor.2013.08.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
70 Millard T, Kunk PR, Ramsdale E, Rahma OE. Current debate in the oncologic management of rectal cancer. World J Gastrointest Oncol 2016; 8(10): 715-724 [PMID: 27795811 DOI: 10.4251/wjgo.v8.i10.715] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
71 Sainato A, Cernusco Luna Nunzia V, Valentini V, De Paoli A, Maurizi ER, Lupattelli M, Aristei C, Vidali C, Conti M, Galardi A, Ponticelli P, Friso ML, Iannone T, Osti FM, Manfredi B, Coppola M, Orlandini C, Cionini L. No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT). Radiother Oncol. 2014;113:223-229. [PMID: 25454175 DOI: 10.1016/j.radonc.2014.10.006] [Cited by in Crossref: 149] [Cited by in F6Publishing: 135] [Article Influence: 21.3] [Reference Citation Analysis]
72 Yang DD, Muralidhar V, Mahal BA, Beard CJ, Mouw KW, Martin NE, Orio PF 3rd, King MT, Nguyen PL. Travel Distance as a Barrier to Receipt of Adjuvant Radiation Therapy After Radical Prostatectomy. Am J Clin Oncol 2018;41:953-9. [PMID: 29045266 DOI: 10.1097/COC.0000000000000410] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
73 Siegel R, Burock S, Wernecke KD, Kretzschmar A, Dietel M, Loy V, Koswig S, Budach V, Schlag PM. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer. 2009;9:50. [PMID: 19200365 DOI: 10.1186/1471-2407-9-501471-2407-9-50] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Lewis S, Talapatra K. Radiotherapy management of rectal cancer in the backdrop of the COVID pandemic. Cancer Rep (Hoboken) 2021;4:e1320. [PMID: 33295140 DOI: 10.1002/cnr2.1320] [Reference Citation Analysis]
75 Brændengen M, Tveit KM, Berglund Å, Birkemeyer E, Frykholm G, Påhlman L, Wiig JN, Byström P, Bujko K, Glimelius B. Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer. JCO 2008;26:3687-94. [DOI: 10.1200/jco.2007.15.3858] [Cited by in Crossref: 296] [Cited by in F6Publishing: 75] [Article Influence: 22.8] [Reference Citation Analysis]
76 Glynne-jones R. Do T3 Rectal Cancers Always Need Radiochemotherapy? In: Otto F, Lutz MP, editors. Early Gastrointestinal Cancers II: Rectal Cancer. Cham: Springer International Publishing; 2014. pp. 95-115. [DOI: 10.1007/978-3-319-08060-4_9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
77 Nicholls J. The multidisciplinary management of rectal cancer. Colorectal Dis. 2008;10:311-313. [PMID: 18412712 DOI: 10.1111/j.1463-1318.2008.01525.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
78 Kachnic LA, Hong TS, Ryan DP. Rectal Cancer at the Crossroads: The Dilemma of Clinically Staged T3, N0, M0 Disease. JCO 2008;26:350-1. [DOI: 10.1200/jco.2007.14.6365] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
79 Naiken SP, Toso C, Rubbia-Brandt L, Thomopoulos T, Roth A, Mentha G, Morel P, Gervaz P. Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer. BMC Surg 2014;14:4. [PMID: 24438090 DOI: 10.1186/1471-2482-14-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
80 Glynne-Jones R, Harrison M. Locally advanced rectal cancer: what is the evidence for induction chemoradiation? Oncologist. 2007;12:1309-1318. [PMID: 18055850 DOI: 10.1634/theoncologist.12-11-1309] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
81 Kerr SF, Norton S, Glynne-Jones R. Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg. 2008;95:1534-1540. [PMID: 18942057 DOI: 10.1002/bjs.6377] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 6.8] [Reference Citation Analysis]
82 Bisceglia G, Mastrodonato N, Tardio B, Mazzoccoli G, Corsa P, Troiano M, Parisi S. Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial. Oncotarget 2014;5:11143-53. [PMID: 25373926 DOI: 10.18632/oncotarget.2603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Glimelius B. Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future. Ups J Med Sci 2012;117:225-36. [PMID: 22512246 DOI: 10.3109/03009734.2012.658974] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
84 Pettersson D, Cedermark B, Holm T, Radu C, Påhlman L, Glimelius B, Martling A. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010;97:580-7. [PMID: 20155787 DOI: 10.1002/bjs.6914] [Cited by in Crossref: 182] [Cited by in F6Publishing: 143] [Article Influence: 16.5] [Reference Citation Analysis]
85 Napolitano M, D'Alterio C, Cardone E, Trotta AM, Pecori B, Rega D, Pace U, Scala D, Scognamiglio G, Tatangelo F, Cacciapuoti C, Pacelli R, Delrio P, Scala S. Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients. Oncotarget 2015;6:8261-70. [PMID: 25823653 DOI: 10.18632/oncotarget.3014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
86 Glynne-Jones R, Hall M, Nagtegaal ID. The optimal timing for the interval to surgery after short course preoperative radiotherapy (5 ×5 Gy) in rectal cancer - are we too eager for surgery? Cancer Treat Rev 2020;90:102104. [PMID: 33002819 DOI: 10.1016/j.ctrv.2020.102104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
87 Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-levra N, Ricchetti F, Ruggieri R, Di Paola G, Cirillo M, Gori S, Salgarello M, Zamboni G, Ruffo G. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer. Clin Transl Oncol 2017;19:189-96. [DOI: 10.1007/s12094-016-1522-0] [Reference Citation Analysis]
88 Moslim MA, Bastawrous AL, Jeyarajah DR. Neoadjuvant Pelvic Radiotherapy in the Management of Rectal Cancer with Synchronous Liver Metastases: Is It Worth It? J Gastrointest Surg 2021. [PMID: 34100244 DOI: 10.1007/s11605-021-05042-w] [Reference Citation Analysis]
89 Avallone A, Aloj L, Aprile G, Rosati G, Budillon A. A perspective on the current treatment strategies for locally advanced rectal cancer. Int J Biochem Cell Biol 2015;65:192-6. [PMID: 26055517 DOI: 10.1016/j.biocel.2015.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
90 Minsky BD, Rödel C, Valentini V. Preoperative therapy for rectal cancer: Short-course radiation vs. long-course chemoradiation. Seminars in Colon and Rectal Surgery 2014;25:19-21. [DOI: 10.1053/j.scrs.2013.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
91 Glynne-Jones R. Neoadjuvant treatment in rectal cancer: do we always need radiotherapy-or can we risk assess locally advanced rectal cancer better? Recent Results Cancer Res. 2012;196:21-36. [PMID: 23129364 DOI: 10.1007/978-3-642-31629-6_2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
92 Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 2012;17:1-29. [PMID: 22002491 DOI: 10.1007/s10147-011-0315-2] [Cited by in Crossref: 491] [Cited by in F6Publishing: 480] [Article Influence: 49.1] [Reference Citation Analysis]
93 Sher DJ. Cost-effectiveness studies in radiation therapy. Expert Rev Pharmacoecon Outcomes Res. 2010;10:567-582. [PMID: 20950072 DOI: 10.1586/erp.10.51] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
94 den Dulk M, Putter H, Collette L, Marijnen CA, Folkesson J, Bosset J, Rödel C, Bujko K, Påhlman L, van de Velde CJ. The abdominoperineal resection itself is associated with an adverse outcome: The European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. European Journal of Cancer 2009;45:1175-83. [DOI: 10.1016/j.ejca.2008.11.039] [Cited by in Crossref: 135] [Cited by in F6Publishing: 112] [Article Influence: 11.3] [Reference Citation Analysis]
95 Baranyai Z, Sinkó D, Jósa V, Zaránd A, Teknos D. [Therapy of radiation enteritis--current challenges]. Orv Hetil 2011;152:1120-4. [PMID: 21712173 DOI: 10.1556/OH.2011.29141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Garant A, Kavan P, Martin AG, Azoulay L, Vendrely V, Lavoie C, Vasilevsky CA, Boutros M, Faria J, Nguyen TN, Ferland E, Des Groseilliers S, Cloutier AS, Diec H, Drolet S, Richard C, Batist G, Vuong T. Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial. Radiother Oncol 2021;155:237-45. [PMID: 33220397 DOI: 10.1016/j.radonc.2020.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
97 Patel JA, Fleshman JW, Hunt SR, Safar B, Birnbaum EH, Lin AY, Mutch MG. Is an Elective Diverting Colostomy Warranted in Patients With an Endoscopically Obstructing Rectal Cancer Before Neoadjuvant Chemotherapy? Diseases of the Colon & Rectum 2012;55:249-55. [DOI: 10.1097/dcr.0b013e3182411a8f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
98 Thomson DJ, Yom SS, Saeed H, El Naqa I, Ballas L, Bentzen SM, Chao ST, Choudhury A, Coles CE, Dover L, Guadagnolo BA, Guckenberger M, Hoskin P, Jabbour SK, Katz MS, Mukherjee S, Rembielak A, Sebag-Montefiore D, Sher DJ, Terezakis SA, Thomas TV, Vogel J, Estes C. Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development. Int J Radiat Oncol Biol Phys 2020;108:379-89. [PMID: 32798063 DOI: 10.1016/j.ijrobp.2020.06.054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
99 Weber GF, Rosenberg R, Murphy JE, Meyer zum Büschenfelde C, Friess H. Multimodal treatment strategies for locally advanced rectal cancer. Expert Rev Anticancer Ther 2012;12:481-94. [PMID: 22500685 DOI: 10.1586/era.12.3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
100 Park J, Neuman HB, Weiser MR, Wong WD. Randomized clinical trials in rectal and anal cancers. Surg Oncol Clin N Am 2010;19:205-23. [PMID: 19914567 DOI: 10.1016/j.soc.2009.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
101 Roy A, Mahasittiwat P, Weiner AA, Hunt SR, Mutch MG, Birnbaum EH, Kodner IJ, Read TE, Fleshman JW, Olsen JR, Myerson RJ, Parikh PJ. Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: Results from a single US institution. Pract Radiat Oncol 2017;7:e51-8. [PMID: 27720702 DOI: 10.1016/j.prro.2016.08.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
102 Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J, Sun W. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3:e2030097. [PMID: 33326026 DOI: 10.1001/jamanetworkopen.2020.30097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
103 Frasson M, Garcia-granero E, Roda D, Flor-lorente B, Roselló S, Esclapez P, Faus C, Navarro S, Campos S, Cervantes A. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer. Cancer 2011;117:3118-25. [DOI: 10.1002/cncr.25866] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
104 Kane C, Glynne-jones R. Should we favour the use of 5 × 5 preoperative radiation in rectal cancer. Cancer Treatment Reviews 2019;81:101908. [DOI: 10.1016/j.ctrv.2019.101908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
105 Smart CJ, Korsgen S, Hill J, Speake D, Levy B, Steward M, Geh JI, Robinson J, Sebag-montefiore D, Bach SP. Multicentre study of short-course radiotherapy and transanal endoscopic microsurgery for early rectal cancer. British Journal of Surgery 2016;103:1069-75. [DOI: 10.1002/bjs.10171] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
106 Qin Q, Huang B, Cao W, Zhou J, Ma T, Zhou Z, Wang J, Wang L. Bowel Dysfunction After Low Anterior Resection With Neoadjuvant Chemoradiotherapy or Chemotherapy Alone for Rectal Cancer: A Cross-Sectional Study from China. Dis Colon Rectum 2017;60:697-705. [PMID: 28594719 DOI: 10.1097/DCR.0000000000000801] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
107 Chua YJ, Barbachano Y, Cunningham D, Oates JR, Brown G, Wotherspoon A, Tait D, Massey A, Tebbutt NC, Chau I. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol. 2010;11:241-248. [PMID: 20106720 DOI: 10.1016/s1470-2045(09)70381-x] [Cited by in Crossref: 229] [Cited by in F6Publishing: 90] [Article Influence: 20.8] [Reference Citation Analysis]
108 Tsujinaka S, Kawamura YJ, Konishi F, Aihara H, Maeda T, Mizokami K. Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer. Int J Colorectal Dis 2007;23:67-76. [DOI: 10.1007/s00384-007-0369-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
109 Ni X, Yang J, Li M. Imaging-guided curative surgical resection of pancreatic cancer in a xenograft mouse model. Cancer Lett. 2012;324:179-185. [PMID: 22617626 DOI: 10.1016/j.canlet.2012.05.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
110 Hur H, Tulina I, Cho MS, Min BS, Koom WS, Lim JS, Ahn JB, Kim NK. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis. Dis Colon Rectum 2016;59:1174-82. [PMID: 27824703 DOI: 10.1097/DCR.0000000000000711] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
111 Radu C, Berglund Å, Påhlman L, Glimelius B. Short-course preoperative radiotherapy with delayed surgery in rectal cancer – A retrospective study. Radiotherapy and Oncology 2008;87:343-9. [DOI: 10.1016/j.radonc.2007.11.025] [Cited by in Crossref: 157] [Cited by in F6Publishing: 132] [Article Influence: 12.1] [Reference Citation Analysis]
112 Lindebjerg J, Spindler KL, Ploen J, Jakobsen A. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy. Colorectal Dis. 2009;11:264-269. [PMID: 18573119 DOI: 10.1111/j.1463-1318.2008.01599.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
113 Fokas E, Glynne-Jones R, Appelt A, Beets-Tan R, Beets G, Haustermans K, Marijnen C, Minsky BD, Ludmir E, Quirke P, Sebag-Montefiore D, Garcia-Aguilar J, Gambacorta MA, Valentini V, Buyse M, Rödel C. Outcome measures in multimodal rectal cancer trials. Lancet Oncol 2020;21:e252-64. [PMID: 32359501 DOI: 10.1016/S1470-2045(20)30024-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 14.0] [Reference Citation Analysis]
114 Zlobec I, Vuong T, Compton CC, Lugli A, Michel RP, Hayashi S, Jass JR. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy. Br J Cancer. 2008;98:450-456. [PMID: 18182986 DOI: 10.1038/sj.bjc.6604172] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
115 Osterman E, Hammarström K, Imam I, Osterlund E, Sjöblom T, Glimelius B. Recurrence Risk after Radical Colorectal Cancer Surgery-Less Than before, But How High Is It? Cancers (Basel) 2020;12:E3308. [PMID: 33182510 DOI: 10.3390/cancers12113308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
116 Van Cutsem E, Dicato M, Haustermans K, Arber N, Bosset JF, Cunningham D, De Gramont A, Diaz-Rubio E, Ducreux M, Goldberg R, Glynne-Jones R, Haller D, Kang YK, Kerr D, Labianca R, Minsky BD, Moore M, Nordlinger B, Rougier P, Scheithauer W, Schmoll HJ, Sobrero A, Tabernero J, Tempero M, Van de Velde C, Zalcberg J. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. Ann Oncol. 2008;19 Suppl 6:vi1-vi8. [PMID: 18539618 DOI: 10.1093/annonc/mdn358] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
117 Jacques AE, Rockall AG, Alijani M, Hughes J, Babar S, Aleong JA, Cottrill C, Dorudi S, Reznek RH. MRI demonstration of the effect of neoadjuvant radiotherapy on rectal carcinoma. Acta Oncol 2007;46:989-95. [PMID: 17851843 DOI: 10.1080/02841860701317865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
118 Belluco C, De Paoli A, Canzonieri V, Sigon R, Fornasarig M, Buonadonna A, Boz G, Innocente R, Perin T, Cossaro M, Polesel J, De Marchi F. Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol 2011;18:3686-93. [PMID: 21691880 DOI: 10.1245/s10434-011-1822-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
119 Wahba HA, El-Hadaad HA, Roshdy S. Combination of irinotecan and 5-fluorouracil with radiation in locally advanced rectal adenocarcinoma. J Gastrointest Cancer 2012;43:467-71. [PMID: 22147447 DOI: 10.1007/s12029-011-9350-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Dirican B, Beyzadeoglu M. A Concise Review of Pelvic Radiation Therapy (RT) for Rectal Cancer with Synchronous Liver Metastases. Int J Surg Oncol 2019;2019:5239042. [PMID: 31139467 DOI: 10.1155/2019/5239042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Hong TS, Mamon H. Short-course versus standard chemoradiation in T3 rectal cancer. Oncologist 2011;16:717-21. [PMID: 21586661 DOI: 10.1634/theoncologist.2011-0052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
122 Marijnen CA. Organ preservation in rectal cancer: have all questions been answered? Lancet Oncol 2015;16:e13-22. [PMID: 25638548 DOI: 10.1016/S1470-2045(14)70398-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 19] [Article Influence: 7.9] [Reference Citation Analysis]
123 Chan T, Smith RK. History of neoadjuvant therapy for rectal cancer. Seminars in Colon and Rectal Surgery 2019;30:58-62. [DOI: 10.1053/j.scrs.2019.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Lee SF, Chiang CL, Lee FAS, Wong YW, Poon CM, Wong FCS, Tung SY. Outcome of neoadjuvant chemoradiation in MRI staged locally advanced rectal cancer: Retrospective analysis of 123 Chinese patients. Journal of the Formosan Medical Association 2018;117:825-32. [DOI: 10.1016/j.jfma.2017.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
125 Haddock MG. Irradiation of Very Locally Advanced and Recurrent Rectal Cancer. Semin Radiat Oncol 2016;26:226-35. [PMID: 27238475 DOI: 10.1016/j.semradonc.2016.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
126 Räsänen M, Renkonen-Sinisalo L, Mustonen H, Lepistö A. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study. World J Surg Oncol 2019;17:139. [PMID: 31395058 DOI: 10.1186/s12957-019-1670-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
127 Kang YM, Chao TF, Wang TH, Hu YW. Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study. Cancer Med 2019;8:3639-47. [PMID: 31104362 DOI: 10.1002/cam4.2030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
128 Hingorani M, Hartley JE, Greenman J, Macfie J. Avoiding radical surgery after pre-operative chemoradiotherapy: a possible therapeutic option in rectal cancer? Acta Oncol. 2012;51:275-284. [PMID: 22150079 DOI: 10.3109/0284186x.2011.636756] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
129 Passardi A, Rapposelli IG, Scarpi E, Neri E, Parisi E, Ghigi G, Ercolani G, Avanzolini A, Cavaliere D, Rudnas B, Valgiusti M, Barone D, Ferroni F, Frassineti GL, Romeo A. Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial. Ther Adv Med Oncol 2020;12:1758835920977139. [PMID: 33343722 DOI: 10.1177/1758835920977139] [Reference Citation Analysis]
130 Ahmed S, Eng C. Neoadjuvant Strategies: Locally Advanced Rectal Cancer. Clin Colon Rectal Surg. 2017;30:383-386. [PMID: 29184474 DOI: 10.1055/s-0037-1606372] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
131 Thavaneswaran S, Price TJ. Optimal therapy for resectable rectal cancer. Expert Rev Anticancer Ther 2016;16:285-302. [PMID: 26652907 DOI: 10.1586/14737140.2016.1130627] [Reference Citation Analysis]
132 Yang Y, Liu Q, Jia B, Du X, Dai G, Liu H, Chen J, Zeng M, Wen K, Zhu Y, Wang Y, Feng L. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer. Technol Cancer Res Treat 2019;18:1533033818824367. [PMID: 30803368 DOI: 10.1177/1533033818824367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Damin DC, Lazzaron AR. Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options. World J Gastroenterol 2014; 20(4): 877-887 [PMID: 24574762 DOI: 10.3748/wjg.v20.i4.877] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
134 Abraha I, Aristei C, Palumbo I, Lupattelli M, Trastulli S, Cirocchi R, De Florio R, Valentini V. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. Cochrane Database Syst Rev. 2018;10:CD002102. [PMID: 30284239 DOI: 10.1002/14651858.cd002102.pub3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
135 Ali F, Keshinro A, Weiser MR. Advances in the treatment of locally advanced rectal cancer. Ann Gastroenterol Surg 2021;5:32-8. [PMID: 33532678 DOI: 10.1002/ags3.12389] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
136 van de Velde CJ, Boelens PG, Borras JM, Coebergh J, Cervantes A, Blomqvist L, Beets-tan RG, van den Broek CB, Brown G, Van Cutsem E, Espin E, Haustermans K, Glimelius B, Iversen LH, van Krieken JH, Marijnen CA, Henning G, Gore-booth J, Meldolesi E, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten H, Schmoll HJ, Smith JJ, Tanis PJ, Taylor C, Wibe A, Wiggers T, Gambacorta MA, Aristei C, Valentini V. EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum. European Journal of Cancer 2014;50:1.e1-1.e34. [DOI: 10.1016/j.ejca.2013.06.048] [Cited by in Crossref: 228] [Cited by in F6Publishing: 218] [Article Influence: 32.6] [Reference Citation Analysis]
137 Chung MJ, Kim DW, Chung WK, Lee SH, Jeong SK, Hwang JK, Jeong CS. Preoperative short- vs. long-course chemoradiotherapy with delayed surgery for locally advanced rectal cancer. Oncotarget 2017;8:60479-86. [PMID: 28947986 DOI: 10.18632/oncotarget.10280] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
138 Joye I, Silversmit G, Van Eycken E, Debucquoy A, Vandendael T, Penninckx F, Haustermans K. Survival among clinical stage I-III rectal cancer patients treated with different preoperative treatments: A population-based comparison. Cancer Epidemiol 2016;43:35-41. [PMID: 27388565 DOI: 10.1016/j.canep.2016.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
139 Gelsomino F, Spallanzani A, Garajovà I. The treatment of rectal cancer with synchronous liver metastases: A matter of strategy. Critical Reviews in Oncology/Hematology 2019;139:91-5. [DOI: 10.1016/j.critrevonc.2019.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
140 Lee SW, Lee JH, Lee IK, Oh ST, Kim DY, Kim TH, Oh JH, Baek JY, Chang HJ, Park HC, Kim HC, Chie EK, Nam TK, Jang HS. The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma. Cancer Res Treat 2018;50:1039-50. [PMID: 29161802 DOI: 10.4143/crt.2017.252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Fields EC, Kaplan BJ, Karlin J, Myers JL, Mukhopadhyay N, Deng X, Sankala H, Grossman SR, Matin K. Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer. Adv Radiat Oncol 2019;4:605-12. [PMID: 31673654 DOI: 10.1016/j.adro.2019.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Minsky BD. Emerging trends in the treatment of rectal cancer. Acta Oncol. 2019;58:1343-1351. [PMID: 31271081 DOI: 10.1080/0284186x.2019.1629009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
143 Nout R, Devic S, Niazi T, Wyse J, Boutros M, Pelsser V, Vuong T. CT-based adaptive high-dose-rate endorectal brachytherapy in the preoperative treatment of locally advanced rectal cancer: Technical and practical aspects. Brachytherapy 2016;15:477-84. [DOI: 10.1016/j.brachy.2016.03.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
144 Glimelius B, Oliveira J. Rectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology 2009;20:iv54-6. [DOI: 10.1093/annonc/mdp128] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
145 Bauman G, Ferguson M, Lock M, Chen J, Ahmad B, Venkatesan V, Sexton T, D'souza D, Loblaw A, Warner A, Rodrigues G. A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 2015;92:856-62. [DOI: 10.1016/j.ijrobp.2015.02.046] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
146 Hervás Morón A, García de Paredes ML, Lobo Martínez E. Multidisciplinary management in rectal cancer. Clin Transl Oncol 2010;12:805-18. [DOI: 10.1007/s12094-010-0602-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
147 Suwinski R, Wzietek I, Tarnawski R, Namysl-kaletka A, Kryj M, Chmielarz A, Wydmanski J. Moderately Low Alpha/Beta Ratio for Rectal Cancer May Best Explain the Outcome of Three Fractionation Schedules of Preoperative Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2007;69:793-9. [DOI: 10.1016/j.ijrobp.2007.03.046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
148 Orsini RG, Vermeer TA, Traa MJ, Nieuwenhuijzen GAP, de Hingh IHJT, Rutten HJT. Does Extended Surgery Influence Health-Related Quality of Life in Patients With Rectal Cancer? Diseases of the Colon & Rectum 2015;58:179-85. [DOI: 10.1097/dcr.0000000000000292] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
149 Rivera S, Villa J, Quero L, Hennequin C. Adjuvant radiotherapy for rectal cancer: recent results, new questions. Clin Res Hepatol Gastroenterol. 2011;35:17-22. [PMID: 21185664 DOI: 10.1016/j.gcb.2010.07.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
150 Créhange G, Bosset JF, Maingon P. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies]. Cancer Radiother 2011;15:440-4. [PMID: 21802334 DOI: 10.1016/j.canrad.2011.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
151 Huang W, Dang J, Li Y, Cui HX, Lu WL, Jiang QF. Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy. Front Oncol 2021;11:646211. [PMID: 33968746 DOI: 10.3389/fonc.2021.646211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 De Bari B, Bosset JF, Gérard JP, Maingon P, Valentini V. [Multidisciplinary management of rectal cancer]. Cancer Radiother. 2012;16:711-720. [PMID: 23182080 DOI: 10.1016/j.canrad.2012.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
153 Lee JH, Kim DY, Nam TK, Yoon SC, Lee DS, Park JW, Oh JH, Chang HJ, Yoon MS, Jeong JU, Jang HS. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01). Int J Radiat Oncol Biol Phys 2012;84:955-61. [PMID: 22537540 DOI: 10.1016/j.ijrobp.2012.01.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
154 Le Compte M, Komen N, Joye I, Peeters M, Prenen H, Smits E, Deben C, de Maat M. Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies. Crit Rev Oncol Hematol 2021;157:103190. [PMID: 33310278 DOI: 10.1016/j.critrevonc.2020.103190] [Reference Citation Analysis]
155 Papaccio F, Roselló S, Huerta M, Gambardella V, Tarazona N, Fleitas T, Roda D, Cervantes A. Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Cancers (Basel) 2020;12:E3611. [PMID: 33287114 DOI: 10.3390/cancers12123611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
156 Huang Y, Lee D, Young C. Predictors for complete pathological response for stage II and III rectal cancer following neoadjuvant therapy - A systematic review and meta-analysis. Am J Surg 2020;220:300-8. [PMID: 31937416 DOI: 10.1016/j.amjsurg.2020.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
157 Bujko K, Bujko M. Point: short-course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer. Semin Radiat Oncol. 2011;21:220-227. [PMID: 21645867 DOI: 10.1016/j.semradonc.2011.02.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
158 Latkauskas T, Pauzas H, Gineikiene I, Janciauskiene R, Juozaityte E, Saladzinskas Z, Tamelis A, Pavalkis D. Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery. Colorectal Dis. 2012;14:294-298. [PMID: 21899712 DOI: 10.1111/j.1463-1318.2011.02815.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
159 Jeans EB, Jethwa KR, Harmsen WS, Neben-Wittich M, Ashman JB, Merrell KW, Giffey B, Ito S, Kazemba B, Beltran C, Haddock MG, Hallemeier CL. Clinical Implementation of Preoperative Short-Course Pencil Beam Scanning Proton Therapy for Patients With Rectal Cancer. Adv Radiat Oncol 2020;5:865-70. [PMID: 33083648 DOI: 10.1016/j.adro.2020.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
160 Sun Z, Adam MA, Kim J, Turner MC, Fisher DA, Choudhury KR, Czito BG, Migaly J, Mantyh CR. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer. Colorectal Dis 2017;19:1058-66. [PMID: 28586509 DOI: 10.1111/codi.13754] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
161 Park SH, Kim JC. Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules. Radiat Oncol J 2016;34:96-105. [PMID: 27306773 DOI: 10.3857/roj.2016.01704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
162 Smart CJ, Cunningham C, Bach SP. Transanal endoscopic microsurgery. Best Pract Res Clin Gastroenterol. 2014;28:143-157. [PMID: 24485262 DOI: 10.1016/j.bpg.2013.11.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
163 Díaz Beveridge R, Aparicio J, Tormo A, Estevan R, Artes J, Giménez A, Segura Á, Roldán S, Palasí R, Ramos D. Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience. Clin Transl Oncol 2012;14:471-80. [PMID: 22634537 DOI: 10.1007/s12094-012-0826-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
164 Bujko K, Richter P, Smith FM, Polkowski W, Szczepkowski M, Rutkowski A, Dziki A, Pietrzak L, Kołodziejczyk M, Kuśnierz J, Gach T, Kulig J, Nawrocki G, Radziszewski J, Wierzbicki R, Kowalska T, Meissner W, Radkowski A, Paprota K, Polkowski M, Rychter A. Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: a prospective multicentre study. Radiother Oncol 2013;106:198-205. [PMID: 23333016 DOI: 10.1016/j.radonc.2012.12.005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 9.5] [Reference Citation Analysis]
165 Greulich-Bode KM, Zimmermann F, Müller WU, Pakisch B, Molls M, Würschmidt F. Clinical, molecular- and cytogenetic analysis of a case of severe radio-sensitivity. Curr Genomics 2012;13:426-32. [PMID: 23450188 DOI: 10.2174/138920212802510475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
166 García-Albéniz X, Gallego R, Hofheinz RD, Fernández-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Ginés A, Miquel R, Pagés M, Pineda E, Pereira V, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation. World J Gastroenterol 2014; 20(42): 15820-15829 [PMID: 25400468 DOI: 10.3748/wjg.v20.i42.15820] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
167 Jalil O, Claydon L, Arulampalam T. Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer. J Gastrointest Cancer 2015;46:219-36. [PMID: 26133151 DOI: 10.1007/s12029-015-9739-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
168 Solé S, Baeza R, Gabler C, Couñago F. New standard in locally advanced rectal cancer. World J Clin Oncol 2020; 11(12): 990-995 [PMID: 33437661 DOI: 10.5306/wjco.v11.i12.990] [Reference Citation Analysis]
169 Ooi K, Gibbs P, Faragher I. Surgical oncology issues in locally advanced rectal cancer. ANZ J Surg 2011;81:790-6. [PMID: 22295389 DOI: 10.1111/j.1445-2197.2011.05704.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
170 Raldow AC, Hong TS. Will There Be a Clinically Significant Role for Protons in Patients With Gastrointestinal Malignancies? Semin Radiat Oncol 2018;28:125-30. [PMID: 29735188 DOI: 10.1016/j.semradonc.2017.11.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
171 AlQudah M, Salmo E, Haboubi N. The effect of radiotherapy on rectal cancer: a histopathological appraisal and prognostic indicators. Radiat Oncol J 2020;38:77-83. [PMID: 33012150 DOI: 10.3857/roj.2020.00010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Ahmed S, Bathe O, Berry S, Buie D, Davies J, Doll C, Dowden S, Gill S, Gordon V, Hebbard P, Jones E, Kennecke H, Koski S, Krahn M, Le D, Lim H, Lund C, Luo Y, Mcffadden A, Mcghie J, Mulder K, Park J, Rashidi F, Sami A, Tan KT, Wong R. Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014. Curr Oncol 2015;22:e113-23. [PMID: 25908916 DOI: 10.3747/co.22.2362] [Reference Citation Analysis]
173 Kube R, Ptok H, Jacob D, Fahlke J, Mroczkowski P, Lippert H, Ziegenhardt G, Schmidt U, Gastinger I. Modified neoadjuvant short-course radiation therapy in uT3 rectal carcinoma: low local recurrence rate with unchanged overall survival and frequent morbidity. Int J Colorectal Dis 2010;25:109-17. [DOI: 10.1007/s00384-009-0823-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
174 Jain S, Engineer R, Ostwal V, Ramaswamy A, Chopra S, Desouza A, Lewis S, Arya S, Patil P, Saklani A. Addition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasis. Asia Pac J Clin Oncol 2021;17:e70-6. [PMID: 32030912 DOI: 10.1111/ajco.13305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
175 Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, Carlsen E, Tveit KM. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2010;76:1005-1011. [PMID: 19540058 DOI: 10.1016/j.ijrobp.2009.03.010] [Cited by in Crossref: 149] [Cited by in F6Publishing: 132] [Article Influence: 12.4] [Reference Citation Analysis]
176 Swellengrebel HA, Bosch SL, Cats A, Vincent AD, Dewit LG, Verwaal VJ, Nagtegaal ID, Marijnen CA. Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome. Radiother Oncol. 2014;112:44-51. [PMID: 25018000 DOI: 10.1016/j.radonc.2014.05.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
177 Skowron KB, Hurst RD, Umanskiy K, Hyman NH, Shogan BD. Caring for Patients with Rectal Cancer During the COVID-19 Pandemic. J Gastrointest Surg 2020;24:1698-703. [PMID: 32415658 DOI: 10.1007/s11605-020-04645-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
178 Baker B, Salameh H, Al-salman M, Daoud F. How does preoperative radiotherapy affect the rate of sphincter-sparing surgery in rectal cancer? Surgical Oncology 2012;21:e103-9. [DOI: 10.1016/j.suronc.2012.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
179 Song JH, Kim SH, Lee JH, Cho HM, Kim DY, Kim TH, Kim SY, Baek JY, Oh JH, Nam TK, Yoon MS, Jeong JU, Kim K, Chie EK, Jang HS, Kim JS, Kim JH, Kang KM. Significance of histologic tumor grade in rectal cancer treated with preoperative chemoradiotherapy followed by curative surgery: A multi-institutional retrospective study. Radiother Oncol 2016;118:387-92. [PMID: 26763136 DOI: 10.1016/j.radonc.2015.11.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
180 Morris EJ, Finan PJ, Spencer K, Geh I, Crellin A, Quirke P, Thomas JD, Lawton S, Adams R, Sebag-Montefiore D. Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service. Clin Oncol (R Coll Radiol) 2016;28:522-31. [PMID: 26936609 DOI: 10.1016/j.clon.2016.02.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
181 Chang GJ. Rectal Cancer: Watch and Wait. In: Steele SR, Hull TL, Read TE, Saclarides TJ, Senagore AJ, Whitlow CB, editors. The ASCRS Textbook of Colon and Rectal Surgery. Cham: Springer International Publishing; 2016. pp. 507-15. [DOI: 10.1007/978-3-319-25970-3_30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
182 Sineshaw HM, Jemal A, Thomas CR, Mitin T. Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: An analysis from the National Cancer Data Base: Treatment Patterns for Rectal Cancer in US. Cancer 2016;122:1996-2003. [DOI: 10.1002/cncr.29993] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
183 Bigness A, Imanirad I, Sahin IH, Xie H, Frakes J, Hoffe S, Laskowitz D, Felder S. Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation. CA Cancer J Clin 2021;71:198-208. [PMID: 33592118 DOI: 10.3322/caac.21661] [Reference Citation Analysis]
184 Doeksen A, Tanis PJ, Vrouenraets BC, Gooszen JAH, van Lanschot JJB, van Tets WF. Outcome of Rectal Cancer Surgery After the Introduction of Preoperative Radiotherapy in a Low-Volume Hospital. J Gastrointest Canc 2007;38. [DOI: 10.1007/s12029-008-9018-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
185 Kim KH, Shin SJ, Cho MS, Ahn JB, Jung M, Kim TI, Park YS, Kim H, Kim NK, Koom WS. A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis. Radiother Oncol. 2016;118:369-374. [PMID: 26705682 DOI: 10.1016/j.radonc.2015.11.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
186 Beppu N, Matsubara N, Noda M, Yamano T, Kakuno A, Doi H, Kamikonya N, Kimura F, Yamanaka N, Yanagi H, Tomita N. Short-course radiotherapy with delayed surgery vs conventional chemoradiotherapy: A comparison of the short- and long-term outcomes in patients with T3 rectal cancer. Surgery. 2015;158:225-235. [PMID: 25900036 DOI: 10.1016/j.surg.2015.03.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
187 Teng H, Lin J, Lin T, Chen W, Jiang J, Yang S, Wang H, Chang S, Lan Y, Lin C, Lin H, Huang S. Planned Short-Course Radiation (scRT) is Superior to Upfront Concurrent Chemoradiation (CCRT) in Treating Metastatic Rectal Cancer. J Gastrointest Surg 2020;24:1092-100. [DOI: 10.1007/s11605-019-04256-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
188 Bruera G, Di Staso M, Bonfili P, Galvano A, Manetta R, Coletti G, Vicentini R, Guadagni S, Ficorella C, Di Cesare E, Russo A, Ricevuto E. Dose-finding study of oxaliplatin associated to capecitabine-based preoperative chemoradiotherapy in locally advanced rectal cancer. Oncotarget 2018;9:17906-14. [PMID: 29707156 DOI: 10.18632/oncotarget.24665] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
189 Kozak KR, Kachnic LA, Adams J, Crowley EM, Alexander BM, Mamon HJ, Fernandez-del Castillo C, Ryan DP, Delaney TF, Hong TS. Dosimetric Feasibility of Hypofractionated Proton Radiotherapy for Neoadjuvant Pancreatic Cancer Treatment. International Journal of Radiation Oncology*Biology*Physics 2007;68:1557-66. [DOI: 10.1016/j.ijrobp.2007.02.056] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
190 Wadlow RC, Ryan DP. The role of targeted agents in preoperative chemoradiation for rectal cancer. Cancer 2010;116:3537-48. [DOI: 10.1002/cncr.25155] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
191 Podda M, Sylla P, Baiocchi G, Adamina M, Agnoletti V, Agresta F, Ansaloni L, Arezzo A, Avenia N, Biffl W, Biondi A, Bui S, Campanile FC, Carcoforo P, Commisso C, Crucitti A, De'Angelis N, De'Angelis GL, De Filippo M, De Simone B, Di Saverio S, Ercolani G, Fraga GP, Gabrielli F, Gaiani F, Guerrieri M, Guttadauro A, Kluger Y, Leppaniemi AK, Loffredo A, Meschi T, Moore EE, Ortenzi M, Pata F, Parini D, Pisanu A, Poggioli G, Polistena A, Puzziello A, Rondelli F, Sartelli M, Smart N, Sugrue ME, Tejedor P, Vacante M, Coccolini F, Davies J, Catena F. Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian Society of Geriatric Surgery), SIFIPAC (Italian Society of Surgical Pathophysiology), SICE (Italian Society of Endoscopic Surgery and new technologies), and the WSES (World Society of Emergency Surgery) International Consensus Project. World J Emerg Surg 2021;16:35. [PMID: 34215310 DOI: 10.1186/s13017-021-00378-9] [Reference Citation Analysis]
192 Tey J, Leong CN, Cheong WK, Sze TG, Yong WP, Tham IWK, Lee KM. A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer. J Cancer 2017;8:3114-21. [PMID: 29158782 DOI: 10.7150/jca.21237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
193 Giunta EF, Bregni G, Pretta A, Deleporte A, Liberale G, Bali AM, Moretti L, Troiani T, Ciardiello F, Hendlisz A, Sclafani F. Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials. Cancer Treat Rev 2021;96:102177. [PMID: 33798955 DOI: 10.1016/j.ctrv.2021.102177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Musio D, De Felice F, Bulzonetti N, Guarnaccia R, Caiazzo R, Bangrazi C, Raffetto N, Tombolini V. Neoadjuvant-intensified treatment for rectal cancer: Time to change? World J Gastroenterol 2013; 19(20): 3052-3061 [PMID: 23716984 DOI: 10.3748/wjg.v19.i20.3052] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
195 Baltodano PA, Reinhardt ME, Flores JM, Abreu FM, Chattha A, Kone L, Cooney CM, Manahan MA, Zellars RC, Rosson GD. Preoperative Radiotherapy Is Not Associated with Increased Post-mastectomy Short-term Morbidity: Analysis of 77,902 Patients. Plast Reconstr Surg Glob Open 2017;5:e1108. [PMID: 28458959 DOI: 10.1097/GOX.0000000000001108] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
196 Glimelius B. Rectal cancer irradiation. Long course, short course or something else? Acta Oncol 2006;45:1013-7. [PMID: 17118832 DOI: 10.1080/02841860601019413] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
197 Franke AJ, Skelton WP 4th, George TJ, Iqbal A. A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy. Clin Colorectal Cancer 2021;20:1-19. [PMID: 32863179 DOI: 10.1016/j.clcc.2020.07.009] [Reference Citation Analysis]
198 Tan D, Glynne-Jones R. But some neoadjuvant schedules are more equal than others. J Clin Oncol 2013;31:1799-800. [PMID: 23547080 DOI: 10.1200/JCO.2012.47.7844] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
199 Habr-gama A, Perez RO, São Julião GP, Proscurshim I, Gama-rodrigues J. Nonoperative Approaches to Rectal Cancer: A Critical Evaluation. Seminars in Radiation Oncology 2011;21:234-9. [DOI: 10.1016/j.semradonc.2011.02.010] [Cited by in Crossref: 81] [Cited by in F6Publishing: 68] [Article Influence: 8.1] [Reference Citation Analysis]
200 Emmertsen KJ, Laurberg S. Bowel dysfunction after treatment for rectal cancer. Acta Oncol 2008;47:994-1003. [PMID: 18607875 DOI: 10.1080/02841860802195251] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
201 Roeder F, Timke C, Saleh-Ebrahimi L, Schneider L, Hackert T, Hartwig W, Kopp-Schneider A, Hensley FW, Buechler MW, Debus J, Huber PE, Werner J. Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC. BMC Cancer 2012;12:112. [PMID: 22443802 DOI: 10.1186/1471-2407-12-112] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
202 Smith JJ, Garcia-Aguilar J. Advances and challenges in treatment of locally advanced rectal cancer. J Clin Oncol. 2015;33:1797-1808. [PMID: 25918296 DOI: 10.1200/jco.2014.60.1054] [Cited by in Crossref: 98] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
203 Wawok P, Polkowski W, Richter P, Szczepkowski M, Olędzki J, Wierzbicki R, Gach T, Rutkowski A, Dziki A, Kołodziejski L, Sopyło R, Pietrzak L, Kryński J, Wiśniowska K, Spałek M, Pawlewicz K, Polkowski M, Kowalska T, Paprota K, Jankiewicz M, Radkowski A, Chalubińska-Fendler J, Michalski W, Bujko K; Polish Colorectal Cancer Study Group. Preoperative radiotherapy and local excision of rectal cancer: Long-term results of a randomised study. Radiother Oncol 2018;127:396-403. [PMID: 29680321 DOI: 10.1016/j.radonc.2018.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
204 Rana N, Chakravarthy AB, Kachnic LA. Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design. Curr Treat Options Oncol. 2017;18:13. [PMID: 28281215 DOI: 10.1007/s11864-017-0454-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
205 Suh WW, Blackstock AW, Herman J, Konski AA, Mohiuddin M, Poggi MM, Regine WF, Cosman BC, Saltz L, Johnstone PA. ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancer. Int J Radiat Oncol Biol Phys. 2008;70:1427-1430. [PMID: 18374227 DOI: 10.1016/j.ijrobp.2007.09.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
206 Mohiuddin M, Mohiuddin MM, Marks J, Marks G. Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates. Cancer Treat Rev. 2009;35:547-552. [PMID: 19539429 DOI: 10.1016/j.ctrv.2009.05.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
207 Bécouarn Y, Guillo S, Artru P, Assenat E, Bosset J-, Conroy T, Françis E, Taïeb J, Touboul E. Synthèse méthodique: intérêt de la chimiothérapie périopératoire dans la prise en charge des patients atteints d’un adénocarcinome du rectum résécable d’emblée (rapport abrégé). Oncologie 2008;10:226-32. [DOI: 10.1007/s10269-008-0840-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
208 Moesta KT, Köckerling F. Adjuvant radiotherapy for rectal cancer. British Journal of Surgery 2006;93:1035-7. [DOI: 10.1002/bjs.5545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
209 Lombardi R, Cuicchi D, Pinto C, Di Fabio F, Iacopino B, Neri S, Tardio ML, Ceccarelli C, Lecce F, Ugolini G. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment? Ann Surg Oncol. 2010;17:838-845. [PMID: 20012700 DOI: 10.1245/s10434-009-0796-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
210 Socha J, Kairevice L, Kępka L, Michalski W, Spałek M, Paciorek K, Bujko K. Should Short-Course Neoadjuvant Radiation Therapy Be Applied for Low-Lying Rectal Cancer? A Systematic Review and Meta-Analysis of the Randomized Trials. Int J Radiat Oncol Biol Phys 2020;108:1257-64. [PMID: 32634546 DOI: 10.1016/j.ijrobp.2020.06.077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Bebenek M, Wojnar A. Infralevator lymphatic drainage of low-rectal cancers: preliminary results. Ann Surg Oncol. 2009;16:887-892. [PMID: 19165544 DOI: 10.1245/s10434-009-0324-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
212 Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J, Cecconello I. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys. 2008;71:1181-1188. [PMID: 18234443 DOI: 10.1016/j.ijrobp.2007.11.035] [Cited by in Crossref: 137] [Cited by in F6Publishing: 125] [Article Influence: 10.5] [Reference Citation Analysis]
213 Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100:E1-33. [PMID: 23901427 DOI: 10.1002/bjs.9192_1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 9.4] [Reference Citation Analysis]
214 Fung-Kee-Fung SD. Therapeutic approaches in the management of locally advanced rectal cancer. J Gastrointest Oncol 2014;5:353-61. [PMID: 25276408 DOI: 10.3978/j.issn.2078-6891.2014.067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer. 2008;113:57-64. [PMID: 18442099 DOI: 10.1002/cncr.23516] [Cited by in Crossref: 160] [Cited by in F6Publishing: 155] [Article Influence: 12.3] [Reference Citation Analysis]
216 Kho P, Chapuis PH, Beale P, Bokey L, Dent OF, Clarke S. Use of adjuvant chemotherapy in stage C (III) rectal cancer: comparison of data from matched patients in a teaching hospital's clinico-pathological database. Asia Pac J Clin Oncol 2012;8:346-55. [PMID: 22897797 DOI: 10.1111/j.1743-7563.2012.01519.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
217 Mukkai Krishnamurty D, Wise PE. Importance of surgical margins in rectal cancer: Surgical Margins in Rectal Cancer. J Surg Oncol 2016;113:323-32. [DOI: 10.1002/jso.24136] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
218 Sclafani F, Chau I. Timing of Therapies in the Multidisciplinary Treatment of Locally Advanced Rectal Cancer: Available Evidence and Implications for Routine Practice. Semin Radiat Oncol 2016;26:176-85. [PMID: 27238468 DOI: 10.1016/j.semradonc.2016.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
219 Bujko K, Sopyło R. Short-course radiotherapy with delayed surgery for rectal cancer: a third option. Lancet Oncol 2017;18:275-6. [PMID: 28190765 DOI: 10.1016/S1470-2045(17)30075-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
220 Zanelli M, Ciarrocchi A, De Petris G, Zizzo M, Costantini M, Bisagni A, Torricelli F, Nicoli D, Ramundo D, Ricci S, Palicelli A, Sanguedolce F, Ascani S, Castro Ruiz C, Annessi V, Zamponi R, Bortesi M, Martino V, Marchetti M, De Marco L. Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study. Cancers (Basel) 2020;12:E2571. [PMID: 32917028 DOI: 10.3390/cancers12092571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
221 Maliske S, Chau J, Ginader T, Byrn J, Bhatia S, Bellizzi A, Berg DJ, Monga V. Timing of surgery following neoadjuvant chemoradiation in rectal cancer: a retrospective analysis from an academic medical center. J Gastrointest Oncol 2019;10:597-604. [PMID: 31392039 DOI: 10.21037/jgo.2019.02.02] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
222 Minsky BD, Röedel C, Valentini V. Combined modality therapy for rectal cancer. Cancer J. 2010;16:253-261. [PMID: 20526104 DOI: 10.1097/ppo.0b013e3181e0761c] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
223 Wang J, Long Y, Liu K, Pei Q, Zhu H. Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer. BMC Gastroenterol 2021;21:277. [PMID: 34233606 DOI: 10.1186/s12876-021-01851-0] [Reference Citation Analysis]
224 Kosinski L, Habr-Gama A, Ludwig K, Perez R. Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies. CA Cancer J Clin. 2012;62:173-202. [PMID: 22488575 DOI: 10.3322/caac.21138] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
225 Battersby NJ, Moran B, Yu S, Tekkis P, Brown G. MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy. Expert Rev Gastroenterol Hepatol 2014;8:703-19. [PMID: 24954622 DOI: 10.1586/17474124.2014.906898] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
226 Ciammella P, Ruggieri MP, Galeandro M, D’abbiero N, Giunta A, Iotti C. Short-course preoperative radiotherapy combined with chemotherapy in resectable locally advanced rectal cancer: local control and quality of life. Radiol med 2013;118:1397-411. [DOI: 10.1007/s11547-013-0939-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
227 São Julião GP, Habr-gama A, Vailati BB, Perez RO. The good, the bad and the ugly: rectal cancers in the twenty-first century. Tech Coloproctol 2017;21:573-5. [DOI: 10.1007/s10151-017-1651-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
228 Sato T, Ozawa H, Hatate K, Onosato W, Naito M, Nakamura T, Ihara A, Koizumi W, Hayakawa K, Okayasu I, Yamashita K, Watanabe M. A Phase II trial of neoadjuvant preoperative chemoradiotherapy with S-1 plus irinotecan and radiation in patients with locally advanced rectal cancer: clinical feasibility and response rate. Int J Radiat Oncol Biol Phys. 2011;79:677-683. [PMID: 21035953 DOI: 10.1016/j.ijrobp.2009.11.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
229 Mazzola R, Ferrera G, Cucchiara T, Figlia V, Gueci M, Sciumè F, Di Paola G, Scibetta N, Lo Casto A, Pappalardo MP, Lagalla R, Alongi F. Sequential boost in neoadjuvant irradiation for T3N0-1 rectal cancer: long-term results from a single-center experience. Tumori 2016;2016:316-22. [PMID: 27002948 DOI: 10.5301/tj.5000481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
230 Swords DS, Brooke BS, Skarda DE, Stoddard GJ, Tae Kim H, Sause WT, Scaife CL. Facility Variation in Local Staging of Rectal Adenocarcinoma and its Contribution to Underutilization of Neoadjuvant Therapy. J Gastrointest Surg 2019;23:1206-17. [DOI: 10.1007/s11605-018-4039-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
231 Simunovic M, Grubac V, Zbuk K, Wong R, Coates A. Role of the status of the mesorectal fascia in the selection of patients with rectal cancer for preoperative radiation therapy: a retrospective cohort study. Can J Surg 2018;61:332-8. [PMID: 30247008 DOI: 10.1503/cjs.009417] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
232 Bazarbashi S, El-Bassiouni M, Abdelsalam M, Soudy H, Sanea NA, Jabbar AA, Manji M, Fagih M, Ajarim D. A modern regimen of pre-operative concurrent chemo-radiation therapy in locally advanced rectal cancer. J Surg Oncol. 2008;98:167-174. [PMID: 18615536 DOI: 10.1002/jso.21097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
233 Walsh LG, Kenny BJ, El Bassiouni M, Coffey JC. Cancer arising from the remnant mucosa of the ileoanal anastomosis leading to pouchectomy. BMJ Case Rep 2016;2016:bcr2015212802. [PMID: 27481261 DOI: 10.1136/bcr-2015-212802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
234 Hunter C, Brown G. Pre-operative staging of rectal cancer: a review of imaging techniques. Expert Review of Gastroenterology & Hepatology 2016;10:1011-25. [DOI: 10.1080/17474124.2016.1179577] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
235 Skóra T, Nowak-Sadzikowska J, Martynów D, Wszołek M, Sas-Korczyńska B. Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors. J Radiat Oncol 2018;7:77-84. [PMID: 29576860 DOI: 10.1007/s13566-017-0340-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
236 Wang X, Zheng B, Lu X, Bai R, Feng L, Wang Q, Zhao Y, He S. Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data. PLoS One 2018;13:e0200142. [PMID: 30001375 DOI: 10.1371/journal.pone.0200142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
237 Teoh S, Muirhead R. Rectal Radiotherapy-Intensity-modulated Radiotherapy Delivery, Delineation and Doses. Clin Oncol (R Coll Radiol). 2016;28:93-102. [PMID: 26643092 DOI: 10.1016/j.clon.2015.10.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
238 Bujko K, Michalski W, Kepka L, Nowacki MP, Nasierowska-Guttmejer A, Tokar P, Dymecki D, Pawlak M, Lesniak T, Richter P. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial. Int J Radiat Oncol Biol Phys. 2007;67:369-377. [PMID: 17118570 DOI: 10.1016/j.ijrobp.2006.08.065] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
239 Deutsch E, Ezra P, Mangoni M, Ducreux M. Radiotherapy for localized rectal cancer. Ann Oncol 2007;18 Suppl 9:ix105-13. [PMID: 17631562 DOI: 10.1093/annonc/mdm304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
240 Mullen TD, Kim EY, Apisarnthanarax S. Short-Course Radiation Therapy Versus Long-Course Chemoradiation in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer: New Insights from Randomized Trials. Curr Colorectal Cancer Rep 2017;13:165-74. [DOI: 10.1007/s11888-017-0359-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
241 Barbaro B, Fiorucci C, Tebala C, Valentini V, Gambacorta MA, Vecchio FM, Rizzo G, Coco C, Crucitti A, Ratto C, Bonomo L. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009;250:730-9. [PMID: 19244043 DOI: 10.1148/radiol.2503080310] [Cited by in Crossref: 163] [Cited by in F6Publishing: 135] [Article Influence: 13.6] [Reference Citation Analysis]
242 Gao SJ, Corso CD, Wang EH, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2017;12:314-322. [PMID: 27720827 DOI: 10.1016/j.jtho.2016.09.122] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
243 Lancellotti F, Solinas L, Sagnotta A, Mancini S, Cosentino LPM, Belardi A, Battaglia B, Mirri MA, Ciabattoni A, Salerno F, Loponte M. Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option? Eur J Surg Oncol 2021;47:2046-52. [PMID: 33757649 DOI: 10.1016/j.ejso.2021.03.230] [Reference Citation Analysis]
244 Minsky BD. Progress in the Treatment of Locally Advanced Clinically Resectable Rectal Cancer. Clinical Colorectal Cancer 2011;10:227-37. [DOI: 10.1016/j.clcc.2011.06.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
245 Sun W, Dou R, Chen J, Lai S, Zhang C, Ruan L, Kang L, Deng Y, Lan P, Wang L, Wang J. Impact of Long-Course Neoadjuvant Radiation on Postoperative Low Anterior Resection Syndrome and Quality of Life in Rectal Cancer: Post Hoc Analysis of a Randomized Controlled Trial. Ann Surg Oncol. 2019;26:746-755. [PMID: 30536129 DOI: 10.1245/s10434-018-07096-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
246 Pettersson D, Holm T, Iversen H, Blomqvist L, Glimelius B, Martling A. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg. 2012;99:577-583. [PMID: 22241246 DOI: 10.1002/bjs.7796] [Cited by in Crossref: 117] [Cited by in F6Publishing: 101] [Article Influence: 13.0] [Reference Citation Analysis]
247 Nielsen LBJ, Wille-jørgensen P. National and international guidelines for rectal cancer. Colorectal Dis 2014;16:854-65. [DOI: 10.1111/codi.12678] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
248 Maris A, Penninckx F, Devreese AM, Staes F, Moons P, Van Cutsem E, Haustermans K, D'hoore A. Persisting anorectal dysfunction after rectal cancer surgery. Colorectal Dis 2013;15:e672-9. [DOI: 10.1111/codi.12291] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
249 Ma B, Gao P, Song Y, Huang X, Wang H, Xu Q, Zhao S, Wang Z. Short-Course Radiotherapy in Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-analysis. Clinical Colorectal Cancer 2018;17:320-330.e5. [DOI: 10.1016/j.clcc.2018.07.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
250 Haque W, Verma V, Butler EB, Teh BS. Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States. J Gastrointest Oncol 2018;9:601-9. [PMID: 30151256 DOI: 10.21037/jgo.2018.05.08] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
251 Blomqvist L, Glimelius B. The 'good', the 'bad', and the 'ugly' rectal cancers. Acta Oncol. 2008;47:5-8. [PMID: 18097776 DOI: 10.1080/02841860701802585] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
252 Lievens Y, Ricardi U, Poortmans P, Verellen D, Gasparotto C, Verfaillie C, Cortese AJ. Radiation Oncology. Optimal Health for All, Together. ESTRO vision, 2030. Radiotherapy and Oncology 2019;136:86-97. [DOI: 10.1016/j.radonc.2019.03.031] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
253 Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Barni S. Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials. J Gastrointest Oncol 2017;8:39-48. [PMID: 28280607 DOI: 10.21037/jgo.2016.11.03] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
254 Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, Miften M. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010;76:S101-S107. [PMID: 20171503 DOI: 10.1016/j.ijrobp.2009.05.071] [Cited by in Crossref: 327] [Cited by in F6Publishing: 281] [Article Influence: 29.7] [Reference Citation Analysis]
255 Kiran RP, Kirat HT, Burgess AN, Nisar PJ, Kalady MF, Lavery IC. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy? Ann Surg Oncol. 2012;19:1206-1212. [PMID: 21935748 DOI: 10.1245/s10434-011-2044-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
256 Fiorica F, Cartei F, Licata A, Enea M, Ursino S, Colosimo C, Cammà C. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data. Cancer Treat Rev. 2010;36:539-549. [PMID: 20334979 DOI: 10.1016/j.ctrv.2010.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
257 Narang AK, Meyer J. Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer: Trends and Controversies. Curr Oncol Rep 2018;20. [DOI: 10.1007/s11912-018-0714-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
258 Granero-Castro P, Muñoz E, Frasson M, García-Granero A, Esclapez P, Campos S, Flor-Lorente B, Garcia-Granero E. Evaluation of mesorectal fascia in mid and low anterior rectal cancer using endorectal ultrasound is feasible and reliable: a comparison with MRI findings. Dis Colon Rectum 2014;57:709-14. [PMID: 24807595 DOI: 10.1097/DCR.0000000000000096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
259 Engels B, Platteaux N, Van den Begin R, Gevaert T, Sermeus A, Storme G, Verellen D, De Ridder M. Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome. Radiother Oncol. 2014;110:155-159. [PMID: 24239243 DOI: 10.1016/j.radonc.2013.10.026] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
260 Spatola C, Privitera G, Milazzotto R, Tocco A, Acquaviva G, Marletta F, Marino L, Di Grazia A, Salvo R, Cartia G, Platania A, Molino L, Santacaterina A, Mattace Raso M, Frosina P, Ianni R, Bono M, Liardo L, Bonanno S, La Paglia L, Federico M, Fazio I, Mortellaro G, Ferrera G, Tripoli A, Evangelista G, Daidone A, Biti G, Badalamenti M, Ognibene L, Cacciola A, Parisi S, Pergolizzi S. Trends in combined radio-chemotherapy for locally advanced rectal cancer: a survey among radiation oncology centers of Sicily region on behalf of AIRO. Radiol Med 2019;124:671-81. [PMID: 30806918 DOI: 10.1007/s11547-019-01007-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
261 Hong TS, Ryan DP, Blaszkowsky LS, Mamon HJ, Kwak EL, Mino-Kenudson M, Adams J, Yeap B, Winrich B, DeLaney TF. Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head. Int J Radiat Oncol Biol Phys. 2011;79:151-157. [PMID: 20421151 DOI: 10.1016/j.ijrobp.2009.10.061] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
262 Salazar R, Capdevila J, Manzano JL, Pericay C, Martínez-Villacampa M, López C, Losa F, Safont MJ, Gómez-España A, Alonso-Orduña V, Escudero P, Gallego J, García-Paredes B, Palacios A, Biondo S, Grávalos C, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results. BMC Cancer 2020;20:1164. [PMID: 33246428 DOI: 10.1186/s12885-020-07661-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Koseła-Paterczyk H, Teterycz P, Spałek MJ, Borkowska A, Zawadzka A, Wągrodzki M, Szumera-Ciećkiewicz A, Morysiński T, Świtaj T, Ługowska I, Castaneda-Wysocka P, Zdzienicki M, Goryń T, Rutkowski P. Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall. Cancers (Basel) 2021;13:2981. [PMID: 34198676 DOI: 10.3390/cancers13122981] [Reference Citation Analysis]
264 Contin P, Kulu Y, Bruckner T, Sturm M, Welsch T, Müller-stich BP, Huber J, Büchler MW, Ulrich A. Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer. Int J Colorectal Dis 2014;29:165-75. [DOI: 10.1007/s00384-013-1780-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
265 Suhool A, Moszkowicz D, Cudennec T, Vychnevskaia K, Malafosse R, Beauchet A, Julié C, Peschaud F. Optimal oncologic treatment of rectal cancer in patients over 75 years old: Results of a strategy based on oncogeriatric evaluation. J Visc Surg 2018;155:17-25. [PMID: 29503170 DOI: 10.1016/j.jviscsurg.2017.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
266 Konishi T, Watanabe T, Nagawa H, Oya M, Ueno M, Kuroyanagi H, Fujimoto Y, Akiyoshi T, Yamaguchi T, Muto T. Preoperative chemoradiation and extended pelvic lymphadenectomy for rectal cancer: Two distinct principles. World J Gastrointest Surg 2010; 2(4): 95-100 [PMID: 21160857 DOI: 10.4240/wjgs.v2.i4.95] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
267 Valentini V, Glimelius B. Rectal cancer radiotherapy: towards European consensus. Acta Oncol. 2010;49:1206-1216. [PMID: 20843179 DOI: 10.3109/0284186x.2010.506884] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
268 Jensen LH, Altaf R, Harling H, Jensen M, Laurberg S, Lindegaard JC, Muhic A, Vestermark L, Jakobsen A, Bülow S. Clinical outcome in 520 consecutive Danish rectal cancer patients treated with short course preoperative radiotherapy. Eur J Surg Oncol. 2010;36:237-243. [PMID: 19880268 DOI: 10.1016/j.ejso.2009.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
269 Kairevičė L, Latkauskas T, Tamelis A, Petrauskas A, Paužas H, Žvirblis T, Jaruševičius L, Saladžinskas Ž, Pavalkis D, Jančiauskienė R. Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial. Medicina 2017;53:150-8. [DOI: 10.1016/j.medici.2017.05.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
270 Zbar AP, Kennedy PJ, Singh V. Functional outcome following restorative rectal cancer surgery. Acta Chir Iugosl 2009;56:9-16. [PMID: 19780324 DOI: 10.2298/aci0902009z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
271 Wang L, Zhong XG, Peng YF, Li ZW, Gu J. Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions). Colorectal Dis. 2014;16:33-39. [PMID: 23848511 DOI: 10.1111/codi.12354] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
272 Gollins S, Sebag-Montefiore D. Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer. Clin Oncol (R Coll Radiol). 2016;28:146-151. [PMID: 26645661 DOI: 10.1016/j.clon.2015.11.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
273 Wang L, Li YH, Cai Y, Zhan TC, Gu J. Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years. Clin Colorectal Cancer. 2016;15:152-157. [PMID: 26508595 DOI: 10.1016/j.clcc.2015.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
274 Chiang JM, Hsieh PS, Chen JS, Tang R, You JF, Yeh CY. Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy. World J Surg Oncol 2014;12:197. [PMID: 24980147 DOI: 10.1186/1477-7819-12-197] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
275 Wang X, Jin J, Yang Y, Liu WY, Ren H, Feng YR, Xiao Q, Li N, Deng L, Fang H, Jing H, Lu NN, Tang Y, Wang JY, Wang SL, Wang WH, Song YW, Liu YP, Li YX. Adjuvant treatment may benefit patients with high-risk upper rectal cancer: A nomogram and recursive partitioning analysis of 547 patients. Oncotarget 2016;7:66160-9. [PMID: 27449095 DOI: 10.18632/oncotarget.10718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
276 García-cabezas S, Rodríguez-liñán M, Otero-romero AM, Bueno-serrano CM, Gómez-barbadillo J, Palacios-eito A. Respuesta al tratamiento e intervalo de tiempo hasta la cirugía con radioterapia preoperatoria de curso corto en el cáncer de recto. Cirugía Española 2016;94:460-6. [DOI: 10.1016/j.ciresp.2016.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
277 Marijnen CAM, Peters FP, Rödel C, Bujko K, Haustermans K, Fokas E, Glynne-Jones R, Valentini V, Spindler KG, Guren MG, Maingon P, Calvo FA, Pares O, Glimelius B, Sebag-Montefiore D. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. Radiother Oncol 2020;148:213-5. [PMID: 32342861 DOI: 10.1016/j.radonc.2020.03.039] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 36.0] [Reference Citation Analysis]
278 Valentini V, Marijnen C, Beets G, Bujko K, De Bari B, Cervantes A, Chiloiro G, Coco C, Gambacorta MA, Glynne-Jones R, Haustermans K, Meldolesi E, Peters F, Rödel C, Rutten H, van de Velde C, Aristei C. The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. Radiother Oncol 2020;142:6-16. [PMID: 31431374 DOI: 10.1016/j.radonc.2019.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
279 Siegel R, Cuesta MA, Targarona E, Bader FG, Morino M, Corcelles R, Lacy AM, Påhlman L, Haglind E, Bujko K, Bruch HP, Heiss MM, Eikermann M, Neugebauer EA; European Association for Endoscopic Surgery (EAES). Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2011;25:2423-40. [PMID: 21701921 DOI: 10.1007/s00464-011-1805-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
280 Ceelen WP. Progress in rectal cancer treatment. ISRN Gastroenterol 2012;2012:648183. [PMID: 22970381 DOI: 10.5402/2012/648183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
281 Kishan AU, Lamb JM, Jani SS, Kang JJ, Steinberg ML, King CR. Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2015;91:832-9. [PMID: 25752398 DOI: 10.1016/j.ijrobp.2014.11.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
282 Chadi SA, Berho M, Wexner SD. Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature. Langenbecks Arch Surg 2015;400:661-73. [PMID: 26250144 DOI: 10.1007/s00423-015-1328-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
283 Kim NK, Min BS, Kim JS, Hur H, Lee KY, Sohn SK, Cho CH. Oncologic Outcomes and Safety after Tumor-specific Mesorectal Excision for Resectable Rectal Cancer: A Single Institution's Experience with 1,276 Patients with Rectal Cancer. J Korean Soc Coloproctol 2008;24:121. [DOI: 10.3393/jksc.2008.24.2.121] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
284 Grover S, Gudi S, Gandhi AK, Puri PM, Olson AC, Rodin D, Balogun O, Dhillon PK, Sharma DN, Rath GK, Shrivastava SK, Viswanathan AN, Mahantshetty U. Radiation Oncology in India: Challenges and Opportunities. Semin Radiat Oncol 2017;27:158-63. [PMID: 28325242 DOI: 10.1016/j.semradonc.2016.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
285 Wilhelmsen M, Kring T, Jorgensen LN, Madsen MR, Jess P, Bulut O, Nielsen KT, Andersen CL, Nielsen HJ. Determinants of recurrence after intended curative resection for colorectal cancer. Scand J Gastroenterol. 2014;49:1399-1408. [PMID: 25370351 DOI: 10.3109/00365521.2014.926981] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
286 Wong R, Berry S, Spithoff K, Simunovic M, Chan K, Agboola O, Dingle B. Preoperative or Postoperative Therapy for Stage II or III Rectal Cancer: An Updated Practice Guideline. Clinical Oncology 2010;22:265-71. [DOI: 10.1016/j.clon.2010.03.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
287 Rutkowski A, Bujko K, Nowacki MP, Chmielik E, Nasierowska-guttmejer A, Wojnar A; On Behalf of the Polish Colorectal Study Group. Distal Bowel Surgical Margin Shorter than 1 cm After Preoperative Radiation for Rectal Cancer: Is It Safe? Ann Surg Oncol 2008;15:3124-31. [DOI: 10.1245/s10434-008-0125-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
288 Benoist S. [Clinical case: impact of down-staging after neoadjuvant chemoradiotherapy on the treatment and prognosis of rectal cancer]. Gastroenterol Clin Biol 2009;33:289-94. [PMID: 19346092 DOI: 10.1016/j.gcb.2009.02.024] [Reference Citation Analysis]
289 Huang Y, Tai C, Kang Y, Wei P. Early versus delayed surgery after short-course radiotherapy for rectal cancer: A network meta-analysis of randomized Controlled Trials. Asian Journal of Surgery 2020;43:810-8. [DOI: 10.1016/j.asjsur.2019.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Perez RO. Predicting response to neoadjuvant treatment for rectal cancer: a step toward individualized medicine. Dis Colon Rectum. 2011;54:1057-1058. [PMID: 21825883 DOI: 10.1097/dcr.0b013e31822182ce] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
291 Battersby NJ, Juul T, Christensen P, Janjua AZ, Branagan G, Emmertsen KJ, Norton C, Hughes R, Laurberg S, Moran BJ; United Kingdom Low Anterior Resection Syndrome Study Group. Predicting the Risk of Bowel-Related Quality-of-Life Impairment After Restorative Resection for Rectal Cancer: A Multicenter Cross-Sectional Study. Dis Colon Rectum 2016;59:270-80. [PMID: 26953985 DOI: 10.1097/DCR.0000000000000552] [Cited by in Crossref: 82] [Cited by in F6Publishing: 22] [Article Influence: 16.4] [Reference Citation Analysis]
292 Roxburgh CS, Weiser MR. Selective use of radiation for locally advanced rectal cancer: one size does not fit all. Minerva Chir 2018;73:592-600. [PMID: 29806758 DOI: 10.23736/S0026-4733.18.07791-X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007;:CD002102. [PMID: 17443515 DOI: 10.1002/14651858.CD002102.pub2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 4.6] [Reference Citation Analysis]
294 Kennedy ED, Milot L, Fruitman M, Al-Sukhni E, Heine G, Schmocker S, Brown G, McLeod RS. Development and implementation of a synoptic MRI report for preoperative staging of rectal cancer on a population-based level. Dis Colon Rectum 2014;57:700-8. [PMID: 24807594 DOI: 10.1097/DCR.0000000000000123] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
295 Glynne-Jones R, Chau I. Neoadjuvant therapy before surgical treatment. EJC Suppl 2013;11:45-59. [PMID: 26217113 DOI: 10.1016/j.ejcsup.2013.07.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
296 Garajová I, Di Girolamo S, de Rosa F, Corbelli J, Agostini V, Biasco G, Brandi G. Neoadjuvant treatment in rectal cancer: actual status. Chemother Res Pract 2011;2011:839742. [PMID: 22295206 DOI: 10.1155/2011/839742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
297 Arredondo J, Baixauli J, Beorlegui C, Arbea L, Rodríguez J, Sola JJ, Chopitea A, Hernández-lizoáin JL. Prognosis Factors for Recurrence in Patients With Locally Advanced Rectal Cancer Preoperatively Treated With Chemoradiotherapy and Adjuvant Chemotherapy. Diseases of the Colon & Rectum 2013;56:416-21. [DOI: 10.1097/dcr.0b013e318274d9c6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
298 Qiu B, Ding PR, Cai L, Xiao WW, Zeng ZF, Chen G, Lu ZH, Li LR, Wu XJ, Mirimanoff RO, Pan ZZ, Xu RH, Gao YH. Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer. Chin J Cancer. 2016;35:65. [PMID: 27389519 DOI: 10.1186/s40880-016-0126-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
299 Chakrabarti D, Rajan S, Akhtar N, Qayoom S, Gupta S, Verma M, Srivastava K, Kumar V, Bhatt MLB, Gupta R. Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial. Br J Surg 2021;108:511-20. [PMID: 33724296 DOI: 10.1093/bjs/znab020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Minsky BD. Chemoradiation for rectal cancer: rationale, approaches, and controversies. Surg Oncol Clin N Am 2010;19:803-18. [PMID: 20883955 DOI: 10.1016/j.soc.2010.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
301 Popek S, Tsikitis VL. Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior? World J Gastroenterol 2011; 17(7): 848-854 [PMID: 21412494 DOI: 10.3748/wjg.v17.i7.848] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
302 Minsky BD. Counterpoint: Long-Course Chemoradiation Is Preferable in the Neoadjuvant Treatment of Rectal Cancer. Seminars in Radiation Oncology 2011;21:228-33. [DOI: 10.1016/j.semradonc.2011.02.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
303 Glynne-Jones R, Mawdsley S, Harrison M. Cetuximab and chemoradiation for rectal cancer--is the water getting muddy? Acta Oncol. 2010;49:278-286. [PMID: 20180626 DOI: 10.3109/02841860903536010] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
304 Qin Q, Wang L. Neoadjuvant therapy and subsequent treatment in rectal cancer: balance between oncological and functional outcomes. J Anus Rectum Colon 2018;2:47-58. [PMID: 31583321 DOI: 10.23922/jarc.2017-049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
305 Orsini RG, Wiggers T, DeRuiter MC, Quirke P, Beets-Tan RG, van de Velde CJ, Rutten HJ. The modern anatomical surgical approach to localised rectal cancer. EJC Suppl 2013;11:60-71. [PMID: 26217114 DOI: 10.1016/j.ejcsup.2013.07.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
306 Doi H, Beppu N, Odawara S, Tanooka M, Takada Y, Niwa Y, Fujiwara M, Kimura F, Yanagi H, Yamanaka N, Kamikonya N, Hirota S. Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer. J Radiat Res. 2013;54:1118-1124. [PMID: 23658415 DOI: 10.1093/jrr/rrt058] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
307 Choi T, Baek SJ, Kwak JM, Kim J, Kim SH. Early Systemic Failure After Preoperative Chemoradiotherapy for the Treatment of Patients With Rectal Cancer. Ann Coloproctol 2019;35:94-9. [PMID: 31113174 DOI: 10.3393/ac.2018.08.28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
308 Onyeuku NE, Ayala-Peacock DN, Russo SM, Blackstock AW. The multidisciplinary approach to the treatment of rectal cancer: 2015 update. Expert Rev Gastroenterol Hepatol 2015;9:507-17. [PMID: 25431898 DOI: 10.1586/17474124.2015.987753] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
309 Birgisson H, Påhlman L, Gunnarsson U, Glimelius B. Late adverse effects of radiation therapy for rectal cancer - a systematic overview. Acta Oncol 2007;46:504-16. [PMID: 17497318 DOI: 10.1080/02841860701348670] [Cited by in Crossref: 152] [Cited by in F6Publishing: 132] [Article Influence: 11.7] [Reference Citation Analysis]
310 Hoendervangers S, Burbach JPM, Lacle MM, Koopman M, van Grevenstein WMU, Intven MPW, Verkooijen HM. Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol 2020;27:4319-36. [PMID: 32524461 DOI: 10.1245/s10434-020-08615-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
311 Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishihara S, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Boku N, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20:207-239. [PMID: 25782566 DOI: 10.1007/s10147-015-0801-z] [Cited by in Crossref: 379] [Cited by in F6Publishing: 366] [Article Influence: 63.2] [Reference Citation Analysis]
312 Manchon Walsh P, Borràs JM, Ferro T, Espinàs JA; Colorectal Cancer OncoGuia Group. Colorectal cancer OncoGuia. Clin Transl Oncol 2010;12:188-210. [DOI: 10.1007/s12094-010-0489-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
313 Dieguez A. Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging. Cancer Imaging. 2013;13:277-297. [PMID: 23876415 DOI: 10.1102/1470-7330.2013.0028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
314 Torok JA, Palta M, Willett CG, Czito BG. Nonoperative management of rectal cancer: NOM of Rectal Cancer. Cancer 2016;122:34-41. [DOI: 10.1002/cncr.29735] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
315 Ruppert R, Junginger T, Ptok H, Strassburg J, Maurer CA, Brosi P, Sauer J, Baral J, Kreis M, Wollschlaeger D, Hermanek P, Merkel S; OCUM group. Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial. Br J Surg 2018;105:1519-29. [PMID: 29744860 DOI: 10.1002/bjs.10879] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 13.3] [Reference Citation Analysis]
316 Sebag-Montefiore D, Bujko K, Valentini V. Rectal cancer multidisciplinary management: evidences and future landscape. Radiother Oncol. 2009;92:145-147. [PMID: 19596463 DOI: 10.1016/j.radonc.2009.06.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
317 Jin J, Meng H, Zhou G, Xu X, Xue Z, Xu X, Wang F, Lu W, Li X, Zhang H, Deng J. Preoperative Radiotherapy Combined with Capecitabine Chemotherapy in Chinese Patients with Locally Advanced Rectal Cancer. J Gastrointest Surg 2011;15:1858-65. [DOI: 10.1007/s11605-011-1637-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
318 Pach R, Kulig J, Richter P, Gach T, Szura M, Kowalska T. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up. Langenbecks Arch Surg. 2012;397:801-807. [PMID: 22170083 DOI: 10.1007/s00423-011-0890-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
319 Engels B, Tournel K, Everaert H, Hoorens A, Sermeus A, Christian N, Storme G, Verellen D, De Ridder M. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer. Int J Radiat Oncol Biol Phys. 2012;83:142-148. [PMID: 22014952 DOI: 10.1016/j.ijrobp.2011.05.068] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
320 Weiser MR, Zhang Z, Schrag D. Locally Advanced Rectal Cancer: Time for Precision Therapeutics. American Society of Clinical Oncology Educational Book 2015. [DOI: 10.14694/edbook_am.2015.35.e192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
321 Tamini N, Giani A, Famularo S, Montuori M, Giardini V, Gianotti L. Should radical surgery for rectal cancer be offered to elderly population? A propensity-matching analysis on short- and long-term outcomes. Updates Surg 2020;72:801-9. [PMID: 32036561 DOI: 10.1007/s13304-020-00717-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE. Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a Surveillance, Epidemiology, and End Results Patterns-of-Care Study. Int J Radiat Oncol Biol Phys 2011;80:978-84. [PMID: 20961695 DOI: 10.1016/j.ijrobp.2010.03.056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
323 Qiaoli W, Yongping H, Wei X, Guoqiang X, Yunhe J, Qiuyan L, Cheng L, Mengling G, Jiayi L, Wei X, Yi Y. Preoperative short-course radiotherapy (5 × 5 Gy) with delayed surgery versus preoperative long-course radiotherapy for locally resectable rectal cancer: a meta-analysis. Int J Colorectal Dis 2019;34:2171-83. [PMID: 31745621 DOI: 10.1007/s00384-019-03433-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
324 Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, Haustermans K, Maingon P, Overgaard J, Pahlman L. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol. 2009;92:148-163. [PMID: 19595467 DOI: 10.1016/j.radonc.2009.06.027] [Cited by in Crossref: 218] [Cited by in F6Publishing: 184] [Article Influence: 18.2] [Reference Citation Analysis]
325 Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg 2012;99:1211-8. [PMID: 22864880 DOI: 10.1002/bjs.8821] [Cited by in Crossref: 192] [Cited by in F6Publishing: 151] [Article Influence: 21.3] [Reference Citation Analysis]
326 Yuval JB, Thompson HM, Garcia-Aguilar J. Organ Preservation in Rectal Cancer. J Gastrointest Surg 2020;24:1880-8. [PMID: 32314234 DOI: 10.1007/s11605-020-04583-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
327 Imano N, Murakami Y, Kubo K, Kawahara D, Takeuchi Y, Nishibuchi I, Kimura T, Kochi M, Takakura Y, Shimizu W, Egi H, Uegami S, Ohge H, Takahashi S, Ohdan H, Nagata Y. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer. J Radiat Res 2021;62:300-8. [PMID: 33341902 DOI: 10.1093/jrr/rraa117] [Reference Citation Analysis]
328 Dennis K, Zeng L, De Angelis C, Chung H, Coburn N, Chow E, Wong CS. A prospective cohort study of patient-reported vomiting, retching, nausea and antiemetic use during neoadjuvant long-course radiation therapy and concurrent 5-fluorouracil-based chemotherapy for rectal adenocarcinoma. Clin Transl Radiat Oncol 2018;10:42-6. [PMID: 29682620 DOI: 10.1016/j.ctro.2018.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
329 Costas-Chavarri A, Nandakumar G, Temin S, Lopes G, Cervantes A, Cruz Correa M, Engineer R, Hamashima C, Ho GF, Huitzil FD, Malekzadeh Moghani M, Sharara AI, Stern MC, Teh C, Vázquez Manjarrez SE, Verjee A, Yantiss R, Shah MA. Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline. J Glob Oncol 2019;5:1-19. [PMID: 30802158 DOI: 10.1200/JGO.18.00214] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
330 Aghili M, Sotoudeh S, Ghalehtaki R, Babaei M, Farazmand B, Fazeli MS, Keshvari A, Haddad P, Farhan F. Preoperative short course radiotherapy with concurrent and consolidation chemotherapies followed by delayed surgery in locally advanced rectal cancer: preliminary results. Radiat Oncol J 2018;36:17-24. [PMID: 29621870 DOI: 10.3857/roj.2017.00185] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
331 Bujko K, Wyrwicz L, Rutkowski A, Malinowska M, Pietrzak L, Kryński J, Michalski W, Olędzki J, Kuśnierz J, Zając L, Bednarczyk M, Szczepkowski M, Tarnowski W, Kosakowska E, Zwoliński J, Winiarek M, Wiśniowska K, Partycki M, Bęczkowska K, Polkowski W, Styliński R, Wierzbicki R, Bury P, Jankiewicz M, Paprota K, Lewicka M, Ciseł B, Skórzewska M, Mielko J, Bębenek M, Maciejczyk A, Kapturkiewicz B, Dybko A, Hajac Ł, Wojnar A, Leśniak T, Zygulska J, Jantner D, Chudyba E, Zegarski W, Las-Jankowska M, Jankowski M, Kołodziejski L, Radkowski A, Żelazowska-Omiotek U, Czeremszyńska B, Kępka L, Kolb-Sielecki J, Toczko Z, Fedorowicz Z, Dziki A, Danek A, Nawrocki G, Sopyło R, Markiewicz W, Kędzierawski P, Wydmański J; Polish Colorectal Study Group. Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study. Ann Oncol 2016;27:834-42. [PMID: 26884592 DOI: 10.1093/annonc/mdw062] [Cited by in Crossref: 181] [Cited by in F6Publishing: 146] [Article Influence: 36.2] [Reference Citation Analysis]
332 Chua TC, Chong CH, Liauw W, Morris DL. Approach to rectal cancer surgery. Int J Surg Oncol 2012;2012:247107. [PMID: 22792451 DOI: 10.1155/2012/247107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
333 Liauw SL, Minsky BD. The use of capecitabine in the combined-modality therapy for rectal cancer. Clin Colorectal Cancer 2008;7:99-104. [PMID: 18501068 DOI: 10.3816/CCC.2008.n.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
334 Monson JR, Weiser MR, Buie WD, Chang GJ, Rafferty JF, Buie WD, Rafferty J; Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2013;56:535-50. [PMID: 23575392 DOI: 10.1097/DCR.0b013e31828cb66c] [Cited by in Crossref: 262] [Cited by in F6Publishing: 92] [Article Influence: 32.8] [Reference Citation Analysis]
335 Cheng A, Li J, Vaid AK, Ma BBY, Teh C, Ahn JB, Bello M, Charoentum C, Chen L, de Lima Lopes G, Ho GF, Kong HL, Lam KO, Liu TS, Park YS, Sriuranpong V, Sudoyo AW, Wang J, Zhang J, Zhang SZ, Ciardiello F, Köhne C, Shaw M, Kim TW. Adaptation of International Guidelines for Metastatic Colorectal Cancer: An Asian Consensus. Clinical Colorectal Cancer 2014;13:145-55. [DOI: 10.1016/j.clcc.2014.06.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
336 Yeo S, Oh JH, Kim DY, Baek JY, Kim SY, Park JW, Kim MJ, Chang HJ, Kim TH, Lee JH, Jang HS, Kim J, Lee MA, Nam T. Preoperative Short-Course Concurrent Chemoradiation Therapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer: A Phase 2 Multicenter Study (KROG 10-01). International Journal of Radiation Oncology*Biology*Physics 2013;86:34-9. [DOI: 10.1016/j.ijrobp.2012.11.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
337 Hong TS, Ryan DP, Borger DR, Blaszkowsky LS, Yeap BY, Ancukiewicz M, Deshpande V, Shinagare S, Wo JY, Boucher Y, Wadlow RC, Kwak EL, Allen JN, Clark JW, Zhu AX, Ferrone CR, Mamon HJ, Adams J, Winrich B, Grillo T, Jain RK, DeLaney TF, Fernandez-del Castillo C, Duda DG. A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys 2014;89:830-8. [PMID: 24867540 DOI: 10.1016/j.ijrobp.2014.03.034] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 9.7] [Reference Citation Analysis]
338 Spindler KG, Sebag-montefiore D. Why and How Should We Measure the Long-Term Consequences of Rectal Cancer Treatment? Curr Colorectal Cancer Rep 2011;7:97-104. [DOI: 10.1007/s11888-010-0077-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
339 Gural Z, Saglam S, Yucel S, Kaytan-Saglam E, Asoglu O, Ordu C, Acun H, Sharifov R, Onder S, Kizir A, Oral EN. Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study. World J Gastrointest Oncol 2018; 10(1): 40-47 [PMID: 29375747 DOI: 10.4251/wjgo.v10.i1.40] [Reference Citation Analysis]
340 Loree JM, Kennecke HF, Lee-Ying RM, Goodwin RA, Powell ED, Tang PA, Price Hiller JA, Vickers MM, Cheung WY. Impact of Postoperative Adjuvant Chemotherapy Following Long-course Chemoradiotherapy in Stage II Rectal Cancer. Am J Clin Oncol 2018;41:643-8. [PMID: 27819876 DOI: 10.1097/COC.0000000000000342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
341 Jia AY, Narang A, Safar B, Zaheer A, Murphy A, Azad NS, Gearhart S, Fang S, Efron J, Warczynski T, Hacker-Prietz A, Meyer J. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma. Radiat Oncol 2019;14:147. [PMID: 31426827 DOI: 10.1186/s13014-019-1358-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
342 Wo JY, Mamon HJ, Ryan DP, Hong TS. T3N0 rectal cancer: radiation for all? Semin Radiat Oncol 2011;21:212-9. [PMID: 21645866 DOI: 10.1016/j.semradonc.2011.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
343 Vorwerk H, Liersch T, Rothe H, Ghadimi M, Christiansen H, Hess CF, Hermann RM. Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer. Strahlenther Onkol 2009;185:127-33. [DOI: 10.1007/s00066-009-1928-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
344 Jalil O, Afaq A, Ganeshan B, Patel UB, Boone D, Endozo R, Groves A, Sizer B, Arulampalam T. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy. Colorectal Dis 2017;19:349-62. [DOI: 10.1111/codi.13496] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
345 Ngoo AG, Tan AHM, Mushaya CD, Ho Y. Short and long course neoadjuvant therapy compared for management of locally advanced rectal cancer: 11 years' experience at a regional centre. ANZ Journal of Surgery 2020;90:812-20. [DOI: 10.1111/ans.15660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
346 Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-Levra N, Ricchetti F, Ruggieri R, Di Paola G, Cirillo M, Gori S, Salgarello M, Zamboni G, Ruffo G. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer. Clin Transl Oncol 2017;19:189-96. [PMID: 27271749 DOI: 10.1007/s12094-016-1522-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
347 Kim MB, Hong TS, Wo JY. Treatment of stage II-III rectal cancer patients. Curr Oncol Rep 2014;16:362. [PMID: 24323626 DOI: 10.1007/s11912-013-0362-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
348 Glimelius B, Tiret E, Cervantes A, Arnold D; ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi81-vi88. [PMID: 24078665 DOI: 10.1093/annonc/mdt240] [Cited by in Crossref: 313] [Cited by in F6Publishing: 289] [Article Influence: 44.7] [Reference Citation Analysis]
349 Cotte E, Passot G, Decullier E, Maurice C, Glehen O, François Y, Lorchel F, Chapet O, Gerard JP. Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial. Int J Radiat Oncol Biol Phys 2016;94:544-53. [PMID: 26723110 DOI: 10.1016/j.ijrobp.2015.10.061] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
350 Oronsky B, Reid T, Larson C, Knox SJ. Locally advanced rectal cancer: The past, present, and future. Semin Oncol. 2020;47:85-92. [PMID: 32147127 DOI: 10.1053/j.seminoncol.2020.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
351 Mahadevan LS, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, van Triest B, Krishnan S, Hall WA. Imaging predictors of treatment outcomes in rectal cancer: An overview. Critical Reviews in Oncology/Hematology 2018;129:153-62. [DOI: 10.1016/j.critrevonc.2018.06.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
352 Appelt AL, Vogelius IR, Pløen J, Rafaelsen SR, Lindebjerg J, Havelund BM, Bentzen SM, Jakobsen A. Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost. Int J Radiat Oncol Biol Phys 2014;90:110-8. [PMID: 25015203 DOI: 10.1016/j.ijrobp.2014.05.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
353 Zhang GQ, Sahyoun R, Stem M, Lo BD, Rajput A, Efron JE, Atallah C, Safar B. Operative Approach Does Not Impact Radial Margin Positivity in Distal Rectal Cancer. World J Surg 2021;45:3686-94. [PMID: 34495388 DOI: 10.1007/s00268-021-06278-y] [Reference Citation Analysis]
354 Rödel C, Trojan J, Bechstein WO, Woeste G. Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated? Dig Dis. 2012;30 Suppl 2:102-108. [PMID: 23207941 DOI: 10.1159/000342038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
355 Koseła-Paterczyk H, Spałek M, Borkowska A, Teterycz P, Wągrodzki M, Szumera-Ciećkiewicz A, Morysiński T, Castaneda-Wysocka P, Cieszanowski A, Zdzienicki M, Goryń T, Rutkowski P. Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial. J Clin Med 2020;9:E2471. [PMID: 32752185 DOI: 10.3390/jcm9082471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
356 Gollins S, Moran B, Adams R, Cunningham C, Bach S, Myint AS, Renehan A, Karandikar S, Goh V, Prezzi D, Langman G, Ahmedzai S, Geh I. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Multidisciplinary Management. Colorectal Dis. 2017;19 Suppl 1:37-66. [PMID: 28632307 DOI: 10.1111/codi.13705] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
357 Loree JM, Kennecke HF, Renouf DJ, Lim HJ, Vickers MM, Speers CH, Cheung WY. Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy. Clinical Colorectal Cancer 2016;15:352-359.e1. [DOI: 10.1016/j.clcc.2016.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
358 Cèfaro GA, Genovesi D, Vinciguerra A, Augurio A, Di Tommaso M, Marchese R, Borzillo V, Tasciotti L, Taraborrelli M, Innocenti P, Colecchia G, Di Nicola M. Effects of Preoperative Radiochemotherapy with Capecitabine for Resectable Locally Advanced Rectal Cancer in Elderly Patients. Tumori 2012;98:622-9. [DOI: 10.1177/030089161209800513] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
359 Valentini V, Gambacorta MA, Barba MC. Could the surgeon trust to radiotherapy help in rectal cancer? Acta Chir Iugosl 2008;55:55-9. [PMID: 19069693 DOI: 10.2298/aci0803055v] [Reference Citation Analysis]
360 Haustermans K, Debucquoy A, Lambrecht M. The ESTRO Breur Lecture 2010: Toward a tailored patient approach in rectal cancer. Radiotherapy and Oncology 2011;100:15-21. [DOI: 10.1016/j.radonc.2011.05.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
361 Kye BH, Cho HM. Overview of radiation therapy for treating rectal cancer. Ann Coloproctol 2014;30:165-74. [PMID: 25210685 DOI: 10.3393/ac.2014.30.4.165] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
362 Morarasu S, O'Brien L, Clancy C, Dietrich D, Maurer CA, Frasson M, Garcia-Granero E, Martin ST. A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours. Eur J Surg Oncol 2021;47:2421-8. [PMID: 34016500 DOI: 10.1016/j.ejso.2021.05.011] [Reference Citation Analysis]
363 Phang PT, Wang X. Current controversies in neoadjuvant chemoradiation of rectal cancer. Surg Oncol Clin N Am. 2014;23:79-92. [PMID: 24267167 DOI: 10.1016/j.soc.2013.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
364 Caycedo-Marulanda A, Patel SV, Verschoor CP, Uscategui JP, Chadi SA, Moeslein G, Chand M, Maeda Y, Monson JRT, Wexner SD, Mayol J. A Snapshot of the International Views of the Treatment of Rectal Cancer Patients, a Multi-regional Survey: International Tendencies in Rectal Cancer. World J Surg 2021;45:302-12. [PMID: 33033856 DOI: 10.1007/s00268-020-05795-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Papamichael D, Audisio R, Horiot JC, Glimelius B, Sastre J, Mitry E, Van Cutsem E, Gosney M, Köhne CH, Aapro M. Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol. 2009;20:5-16. [PMID: 18922882 DOI: 10.1093/annonc/mdn532] [Cited by in Crossref: 126] [Cited by in F6Publishing: 108] [Article Influence: 9.7] [Reference Citation Analysis]
366 Vernmark K, Sun XF, Holmqvist A. Mucinous and Non-Mucinous Rectal Adenocarcinoma-Differences in Treatment Response to Preoperative Radiotherapy. J Pers Med 2020;10:E226. [PMID: 33202796 DOI: 10.3390/jpm10040226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
367 Hoendervangers S, Sparreboom CL, Intven MPW, Lange JF, Verkooijen HM, Doornebosch PG, van Grevenstein WMU; Dutch ColoRectal Audit. The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study. Eur J Surg Oncol 2020;46:1605-12. [PMID: 32192792 DOI: 10.1016/j.ejso.2020.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
368 Al-Sukhni E, Messenger DE, Charles Victor J, McLeod RS, Kennedy ED. Do MRI reports contain adequate preoperative staging information for end users to make appropriate treatment decisions for rectal cancer? Ann Surg Oncol 2013;20:1148-55. [PMID: 23143592 DOI: 10.1245/s10434-012-2738-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
369 Weiser MR, Quah HM, Shia J, Guillem JG, Paty PB, Temple LK, Goodman KA, Minsky BD, Wong WD. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg. 2009;249:236-242. [PMID: 19212176 DOI: 10.1097/sla.0b013e318195e17c] [Cited by in Crossref: 152] [Cited by in F6Publishing: 51] [Article Influence: 12.7] [Reference Citation Analysis]
370 Miwa K, Oki E, Enomoto M, Ihara K, Ando K, Fujita F, Tominaga M, Mori S, Nakayama G, Shimokawa M, Saeki H, Baba H, Mori M, Akagi Y. Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301). BMC Cancer 2021;21:23. [PMID: 33402130 DOI: 10.1186/s12885-020-07766-5] [Reference Citation Analysis]
371 De Caluwé L, Van Nieuwenhove Y, Ceelen WP; Cochrane Colorectal Cancer Group. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd006041.pub3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 57] [Article Influence: 4.6] [Reference Citation Analysis]
372 Ballonoff A, Kavanagh B, McCarter M, Kane M, Pearlman N, Nash R, Shah RJ, Raben D, Schefter TE. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. Am J Clin Oncol 2008;31:264-70. [PMID: 18525306 DOI: 10.1097/COC.0b013e318161dbd3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
373 Ozden SA, Ozyurt H, Ozgen Z, Kilinc O, Oncel M, Gul AE, Karadayi N, Serakinci N, Kan B, Orun O. Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer. World J Gastroenterol 2011; 17(44): 4905-4910 [PMID: 22171132 DOI: 10.3748/wjg.v17.i44.4905] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
374 Bosch SL, Verhoeven RHA, Lemmens VEPP, Simmer F, Poortmans P, de Wilt JHW, Nagtegaal ID. Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study. Virchows Arch 2019;475:745-55. [PMID: 31463728 DOI: 10.1007/s00428-019-02638-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
375 Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D, Ackland SP, Schache D, McClure B, McLachlan SA, McKendrick J, Leong T, Hartopeanu C, Zalcberg J, Mackay J. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol 2012;30:3827-33. [PMID: 23008301 DOI: 10.1200/JCO.2012.42.9597] [Cited by in Crossref: 458] [Cited by in F6Publishing: 166] [Article Influence: 50.9] [Reference Citation Analysis]
376 Dodaro CA, Calogero A, Tammaro V, Pellegrino T, Lionetti R, Campanile S, Menkulazi M, Ciccozzi M, Iannicelli AM, Giallauria F, Sagnelli C. Colorectal Cancer in the Elderly Patient: The Role of Neo-adjuvant Therapy. Open Med (Wars) 2019;14:607-12. [PMID: 31428685 DOI: 10.1515/med-2019-0068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
377 Vignali A, Nardi PD. Multidisciplinary treatment of rectal cancer in 2014: Where are we going? World J Gastroenterol 2014; 20(32): 11249-11261 [PMID: 25170209 DOI: 10.3748/wjg.v20.i32.11249] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
378 Ye W, Shi L, Qian L, Sun Y, Sun X. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis. Cancer Rep (Hoboken) 2019;2:e1188. [PMID: 32721108 DOI: 10.1002/cnr2.1188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
379 Pucciarelli S, Del Bianco P, Efficace F, Toppan P, Serpentini S, Friso ML, Lonardi S, De Salvo GL, Nitti D. Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery. Support Care Cancer 2010;18:601-8. [DOI: 10.1007/s00520-009-0699-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
380 Mohiuddin M, Marks J, Marks G. Management of rectal cancer: short- vs. long-course preoperative radiation. Int J Radiat Oncol Biol Phys. 2008;72:636-643. [PMID: 19014778 DOI: 10.1016/j.ijrobp.2008.05.069] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
381 Koukourakis GV. Role of radiation therapy in neoadjuvant era in patients with locally advanced rectal cancer. World J Gastrointest Oncol 2012; 4(12): 230-237 [PMID: 23443049 DOI: 10.4251/wjgo.v4.i12.230] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
382 Patel A, Spychalski P, Corrao G, Jereczek-Fossa BA, Glynne-Jones R, Garcia-Aguilar J, Kobiela J. Neoadjuvant short-course radiotherapy with consolidation chemotherapy for locally advanced rectal cancer: a systematic review and meta-analysis. Acta Oncol 2021;:1-9. [PMID: 34308767 DOI: 10.1080/0284186X.2021.1953137] [Reference Citation Analysis]
383 Vonk DT, Hazard LJ. Do all locally advanced rectal cancers require radiation? A review of literature in the modern era. J Gastrointest Oncol. 2010;1:45-54. [PMID: 22811804 DOI: 10.3978/j.issn.2078-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
384 Shi C, Zhou H, Li X, Cai Y. A Retrospective Analysis on Two-week Short-course Pre-operative Radiotherapy in Elderly Patients with Resectable Locally Advanced Rectal Cancer. Sci Rep 2016;6:37866. [PMID: 27886277 DOI: 10.1038/srep37866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
385 Gaertner WB, Kwaan MR, Madoff RD, Melton GB. Rectal cancer: An evidence-based update for primary care providers. World J Gastroenterol 2015; 21(25): 7659-7671 [PMID: 26167068 DOI: 10.3748/wjg.v21.i25.7659] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
386 Vojtíšek R, Korčáková E, Mařan J, Šorejs O, Fínek J. Neoadjuvant chemoradiotherapy of the rectal carcinoma - The correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings. Rep Pract Oncol Radiother 2017;22:265-76. [PMID: 28507455 DOI: 10.1016/j.rpor.2017.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
387 Huang WS, Kuan FC, Lin MH, Chen MF, Chen WC. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer. Ann Surg Oncol 2020;27:4309-18. [PMID: 32794029 DOI: 10.1245/s10434-020-09018-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Horisberger K, Hofheinz RD, Palma P, Volkert AK, Rothenhoefer S, Wenz F, Hochhaus A, Post S, Willeke F. Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? Int J Colorectal Dis. 2008;23:257-264. [PMID: 18071720 DOI: 10.1007/s00384-007-0408-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
389 Yuval JB, Garcia-Aguilar J. Watch-and-wait Management for Rectal Cancer After Clinical Complete Response to Neoadjuvant Therapy. Adv Surg 2021;55:89-107. [PMID: 34389102 DOI: 10.1016/j.yasu.2021.05.007] [Reference Citation Analysis]
390 Kornmann M, Staib L, Wiegel T, Kreuser ED, Kron M, Baumann W, Henne-Bruns D, Link KH. Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α. Br J Cancer 2010;103:1163-72. [PMID: 20877353 DOI: 10.1038/sj.bjc.6605871] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
391 Pucciarelli S, Del Bianco P, Efficace F, Serpentini S, Capirci C, De Paoli A, Amato A, Cuicchi D, Nitti D. Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study. Ann Surg. 2011;253:71-77. [PMID: 21135694 DOI: 10.1097/SLA.0b013e3181fcb856] [Cited by in Crossref: 73] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
392 Colaco RJ, Nichols RC, Huh S, Getman N, Ho MW, Li Z, Morris CG, Mendenhall WM, Mendenhall NP, Hoppe BS. Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer. J Gastrointest Oncol 2014;5:3-8. [PMID: 24490037 DOI: 10.3978/j.issn.2078-6891.2013.041] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
393 Khwaja SS, Roy A, Markovina S, Dewees TA, Hunt S, Tan B, Myerson RJ, Olsen JR, Parikh PJ. Quality of Life Outcomes From a Phase 2 Trial of Short-Course Radiation Therapy Followed by FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 2016;95:1429-38. [DOI: 10.1016/j.ijrobp.2016.03.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
394 Bujko K, Nasierowska-Guttmejer A, Wyrwicz L, Malinowska M, Krynski J, Kosakowska E, Rutkowski A, Pietrzak L, Kepka L, Radziszewski J. Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study. Radiother Oncol. 2013;107:171-177. [PMID: 23590986 DOI: 10.1016/j.radonc.2013.03.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
395 Fleming FJ, Påhlman L, Monson JR. Neoadjuvant therapy in rectal cancer. Dis Colon Rectum 2011;54:901-12. [PMID: 21654259 DOI: 10.1007/DCR.0b013e31820eeb37] [Cited by in Crossref: 64] [Cited by in F6Publishing: 23] [Article Influence: 6.4] [Reference Citation Analysis]
396 Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, Dorth J, Garcia-Aguilar J, Goff D, Jacqmin D, Kelly P, Newman NB, Olsen J, Raldow AC, Ruiz-Garcia E, Stitzenberg KB, Thomas CR Jr, Wu QJ, Das P. Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol 2021;11:13-25. [PMID: 33097436 DOI: 10.1016/j.prro.2020.08.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
397 Hawkins AT, Ford MM, Geiger TM, Hopkins MB, Kachnic LA, Muldoon RL, Glasgow SC. Neoadjuvant radiation for clinical T4 colon cancer: A potential improvement to overall survival. Surgery 2019;165:469-75. [DOI: 10.1016/j.surg.2018.06.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
398 Parc Y, Zutshi M, Zalinski S, Ruppert R, Fürst A, Fazio VW. Preoperative Radiotherapy is Associated with Worse Functional Results After Coloanal Anastomosis for Rectal Cancer. Diseases of the Colon & Rectum 2009;52:2004-14. [DOI: 10.1007/dcr.0b013e3181beb4d8] [Cited by in Crossref: 64] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
399 Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, Gerard JP, Rödel C, Sainato A, Sauer R, Minsky BD, Collette L, Lambin P. Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer. Radiotherapy and Oncology 2015;114:302-9. [DOI: 10.1016/j.radonc.2015.02.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
400 Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Barni S. Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials. J Gastrointest Oncol 2017;8:39-48. [PMID: 28280607 DOI: 10.21037/jgo.2016.11.03] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
401 Muñoz E, Granero-castro P, Frasson M, Escartin J, Esclapez P, Campos S, Flor-lorente B, Garcia-granero E. Modified Wong's Classification Improves the Accuracy of Rectal Cancer Staging by Endorectal Ultrasound and MRI. Diseases of the Colon & Rectum 2013;56:1332-8. [DOI: 10.1097/dcr.0b013e3182a69a3b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
402 Tiselius C, Gunnarsson U, Smedh K, Glimelius B, Påhlman L. Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study. Ann Oncol 2013;24:160-5. [PMID: 22904238 DOI: 10.1093/annonc/mds278] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
403 Moureau-Zabotto L, Ortholan C, Hannoun-Levi JM, Teissier E, Cowen D, Salem N, Lemanski C, Ellis S, Resbeut M. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study). Int J Radiat Oncol Biol Phys 2013;85:e135-42. [PMID: 23195780 DOI: 10.1016/j.ijrobp.2012.09.034] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
404 Erlandsson J, Holm T, Pettersson D, Berglund Å, Cedermark B, Radu C, Johansson H, Machado M, Hjern F, Hallböök O, Syk I, Glimelius B, Martling A. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol 2017;18:336-46. [PMID: 28190762 DOI: 10.1016/S1470-2045(17)30086-4] [Cited by in Crossref: 231] [Cited by in F6Publishing: 91] [Article Influence: 57.8] [Reference Citation Analysis]
405 Lim SH, Chua W, Henderson C, Ng W, Shin JS, Chantrill L, Asghari R, Lee CS, Spring KJ, de Souza P. Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Crit Rev Oncol Hematol 2015;96:67-80. [PMID: 26032919 DOI: 10.1016/j.critrevonc.2015.05.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
406 Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes A, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP;  RAPIDO collaborative investigators. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) vs preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:29-42. [PMID: 33301740 DOI: 10.1016/s1470-2045(20)30555-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 33] [Article Influence: 62.0] [Reference Citation Analysis]
407 Koizumi M, Yamada T, Shinji S, Yokoyama Y, Takahashi G, Iwai T, Takeda K, Hara K, Ohta K, Uchida E, Yoshida H. Feasibility of Neoadjuvant FOLFOX Therapy Without Radiotherapy for Baseline Resectable Rectal Cancer. In Vivo. 2018;32:937-943. [PMID: 29936483 DOI: 10.21873/invivo.11332] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
408 Willey CD, Bonner JA. Interaction of Chemotherapy and Radiation. Clinical Radiation Oncology. Elsevier; 2012. pp. 65-82. [DOI: 10.1016/b978-1-4377-1637-5.00004-3] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
409 Lee M, Gibbs P, Wong R. Multidisciplinary Management of Locally Advanced Rectal Cancer--An Evolving Landscape? Clin Colorectal Cancer. 2015;14:251-261. [PMID: 26210575 DOI: 10.1016/j.clcc.2015.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
410 Ma B, Xu Q, Song Y, Gao P, Wang Z. Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer. Future Oncology 2017;13:2489-501. [DOI: 10.2217/fon-2017-0310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
411 Zhan T, Gu J, Li M, Du C. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer. Dis Colon Rectum. 2013;56:422-432. [PMID: 23478609 DOI: 10.1097/dcr.0b013e31828576c6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
412 Wang L, Zhong X, Lin H, Shao L, Chen G, Wu J. The Correlation Between Survival Benefit of Preoperative Radiotherapy and Pretreatment Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer. Front Oncol 2021;11:735882. [PMID: 34692510 DOI: 10.3389/fonc.2021.735882] [Reference Citation Analysis]
413 Brændengen M, Glimelius B. Preoperative radiotherapy or chemoradiotherapy in rectal cancer - Is survival improved? An update of the "Nordic" LARC study in non-resectable cancers. Radiother Oncol 2018;127:392-5. [PMID: 29778486 DOI: 10.1016/j.radonc.2018.05.004] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
414 Mechera R, Schuster T, Rosenberg R, Speich B. Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis. Eur J Cancer. 2017;72:84-94. [PMID: 28027520 DOI: 10.1016/j.ejca.2016.10.031] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
415 Abdel-Rahman O, Elhalawani HM, Allen PK, Holliday EB. Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States. Adv Radiat Oncol 2018;3:611-20. [PMID: 30370362 DOI: 10.1016/j.adro.2018.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
416 Dalwadi SM, Herman JM, Das P, Holliday EB. Novel Radiotherapy Technologies in the Treatment of Gastrointestinal Malignancies. Hematol Oncol Clin North Am 2020;34:29-43. [PMID: 31739949 DOI: 10.1016/j.hoc.2019.08.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
417 Hughes R, Harrison M, Glynne-Jones R. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy? Acta Oncol. 2010;49:378-381. [PMID: 20151936 DOI: 10.3109/02841860903483692] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
418 Alsughayer A, Grass F, McKenna NP, Petersen M, Mathis KL, Lightner AL. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis. Dis Colon Rectum 2020;63:1265-75. [PMID: 33216497 DOI: 10.1097/DCR.0000000000001666] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
419 Das P, Crane CH. Staging, prognostic factors, and therapy of localized rectal cancer. Curr Oncol Rep 2009;11:167-74. [PMID: 19336008 DOI: 10.1007/s11912-009-0025-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
420 Valentini V, Beets-Tan R, Borras JM, Krivokapić Z, Leer JW, Påhlman L, Rödel C, Schmoll HJ, Scott N, Velde CV, Verfaillie C. Evidence and research in rectal cancer. Radiother Oncol 2008;87:449-74. [PMID: 18534701 DOI: 10.1016/j.radonc.2008.05.022] [Cited by in Crossref: 83] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
421 Glynne-Jones R, Carvalho C. Drug Combinations in Preoperative Chemoradiation for Rectal Cancer. Semin Radiat Oncol 2016;26:211-9. [PMID: 27238473 DOI: 10.1016/j.semradonc.2016.02.002] [Reference Citation Analysis]
422 Glimelius B, Myklebust TÅ, Lundqvist K, Wibe A, Guren MG. Two countries – Two treatment strategies for rectal cancer. Radiotherapy and Oncology 2016;121:357-63. [DOI: 10.1016/j.radonc.2016.11.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
423 Ulrich A, Schwerdt J, Z`graggen K, Kienle P, Weitz J, Büchler MW. Acceptance of neoadjuvant short-term radiotherapy: a survey under surgeons and radiotherapists. Langenbecks Arch Surg 2007;392:525-33. [DOI: 10.1007/s00423-006-0139-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
424 Zhong W, Xue X, Dai L, Li R, Nie K, Zhou S. Neoadjuvant treatments for resectable rectal cancer: A network meta-analysis. Exp Ther Med 2020;19:2604-14. [PMID: 32256740 DOI: 10.3892/etm.2020.8494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
425 Häfner MF, Debus J. Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives. Visc Med 2016;32:172-7. [PMID: 27493944 DOI: 10.1159/000446486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
426 Alvarez-Aguilera M, Jimenez-Rodriguez RM. Watch and wait in locally advance rectal cancer: Past, present and future. World J Meta-Anal 2021; 9(4): 327-332 [DOI: 10.13105/wjma.v9.i4.327] [Reference Citation Analysis]
427 Lorenzon L, Parini D, Rega D, Mellano A, Vigorita V, Biondi A, Jaminez-Rosellon R, Scheiterle M, Giannini I, Gallo G, Marino G, Turati L, Marsanic P, De Franco L, Marano L, De Luca R; Senior SICO Supervising Members(1). Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO). Eur J Surg Oncol 2017;43:1472-80. [PMID: 28571778 DOI: 10.1016/j.ejso.2017.04.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
428 Kim JH. Controversial issues in radiotherapy for rectal cancer: a systematic review. Radiat Oncol J 2017;35:295-305. [PMID: 29325395 DOI: 10.3857/roj.2017.00395] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
429 Nicosia L, Gentile G, Reverberi C, Minniti G, Valeriani M, de Sanctis V, Marinelli L, Cipolla F, de Luca O, Simmaco M, Osti MF. Single nucleotide polymorphism of <italic>GSTP1</italic> and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy. Radiat Oncol J 2018;36:218-26. [PMID: 30309213 DOI: 10.3857/roj.2018.00094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
430 Fujita S, Yamamoto S, Akasu T, Moriya Y. Outcome of patients with clinical stage II or III rectal cancer treated without adjuvant radiotherapy. Int J Colorectal Dis 2008;23:1073-9. [PMID: 18594841 DOI: 10.1007/s00384-008-0513-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
431 Habr-Gama A, Perez RO. Non-operative management of rectal cancer after neoadjuvant chemoradiation. Br J Surg 2009;96:125-7. [PMID: 19160360 DOI: 10.1002/bjs.6470] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 6.7] [Reference Citation Analysis]
432 Pilkington SA, Bhome R, Gilbert S, Harris S, Richardson C, Dudding TC, Knight JS, King AT, Mirnezami AH, Beck NE, Nichols PH, Nugent KP. Sequential assessment of bowel function and anorectal physiology after anterior resection for cancer: a prospective cohort study. Colorectal Dis 2021;23:2436-46. [PMID: 34032359 DOI: 10.1111/codi.15754] [Reference Citation Analysis]
433 Mowery YM, Salama JK, Zafar SY, Moore HG, Willett CG, Czito BG, Hopkins MB, Palta M. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States: SC-RT Versus LC-CRT for Rectal Cancer. Cancer 2017;123:1434-41. [DOI: 10.1002/cncr.30461] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
434 Zhao N, Lin CJ, Wang F, Lin C. Short-course or long-course radiation therapy as a part of a neoadjuvant regimen for stage II & III rectal adenocarcinoma? Chin J Cancer Res 2019;31:849-52. [PMID: 31949387 DOI: 10.21147/j.issn.1000-9604.2019.06.01] [Reference Citation Analysis]
435 Enker WE, Levi GS. Macroscopic assessment of mesorectal excision. Cancer 2009;115:4890-4. [DOI: 10.1002/cncr.24655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
436 Moore A, Den RB, Gordon N, Sarfaty M, Kundel Y, Brenner B, Goldstein DA. The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States. Clinical Colorectal Cancer 2019;18:209-17. [DOI: 10.1016/j.clcc.2019.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
437 Beets GL. Moving forward with organ preservation in rectal cancer. Lancet Gastroenterol Hepatol 2021;6:82-3. [PMID: 33308451 DOI: 10.1016/S2468-1253(20)30390-3] [Reference Citation Analysis]
438 Bujko K, Kolodziejczyk M, Nasierowska-Guttmejer A, Michalski W, Kepka L, Chmielik E, Wojnar A, Chwalinski M. Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation. Radiother Oncol. 2010;95:298-302. [PMID: 20430458 DOI: 10.1016/j.radonc.2010.04.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
439 Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K;  Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1-42. [PMID: 31203527 DOI: 10.1007/s10147-019-01485-z] [Cited by in Crossref: 282] [Cited by in F6Publishing: 269] [Article Influence: 141.0] [Reference Citation Analysis]
440 Kokaine L, Gardovskis A, Gardovskis J. Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy. Medicina (Kaunas) 2021;57:1044. [PMID: 34684080 DOI: 10.3390/medicina57101044] [Reference Citation Analysis]
441 Sautter-Bihl ML, Hohenberger W, Fietkau R, Roedel C, Schmidberger H, Sauer R. MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant? Ann Surg Oncol 2014;21:197-204. [PMID: 24002537 DOI: 10.1245/s10434-013-3236-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
442 Glimelius B, Isacsson U. In reply to Dr Courdi: Biologically equivalent doses (in 2 Gy/fr) to 5×5 Gy. Acta Oncologica 2009;46:396-396. [DOI: 10.1080/02841860701303949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
443 Valentini V, Gambacorta MA, Cellini F, Aristei C, Coco C, Barbaro B, Alfieri S, D'Ugo D, Persiani R, Deodato F, Crucitti A, Lupattelli M, Mantello G, Navarria F, Belluco C, Buonadonna A, Boso C, Lonardi S, Caravatta L, Barba MC, Vecchio FM, Maranzano E, Genovesi D, Doglietto GB, Morganti AG, La Torre G, Pucciarelli S, De Paoli A. The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer. Radiother Oncol 2019;134:110-8. [PMID: 31005204 DOI: 10.1016/j.radonc.2018.11.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
444 Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 2020;5:567-72. [PMID: 32775771 DOI: 10.1016/j.adro.2020.04.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
445 Sahni VA, Silveira PC, Sainani NI, Khorasani R. Impact of a Structured Report Template on the Quality of MRI Reports for Rectal Cancer Staging. AJR Am J Roentgenol 2015;205:584-8. [PMID: 26295645 DOI: 10.2214/AJR.14.14053] [Cited by in Crossref: 66] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
446 McGee SF, AlGhareeb W, Ahmad CH, Armstrong D, Babak S, Berry S, Biagi J, Booth C, Bossé D, Champion P, Colwell B, Finn N, Goel R, Gray S, Green J, Harb M, Hyde A, Jeyakumar A, Jonker D, Kanagaratnam S, Kavan P, MacMillan A, Muinuddin A, Patil N, Porter G, Powell E, Ramjeesingh R, Raza M, Rorke S, Seal M, Servidio-Italiano F, Siddiqui J, Simms J, Smithson L, Snow S, St-Hilaire E, Stuckless T, Tate A, Tehfe M, Thirlwell M, Tsvetkova E, Valdes M, Vickers M, Virik K, Welch S, Marginean C, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference 2017. Curr Oncol 2018;25:262-74. [PMID: 30111967 DOI: 10.3747/co.25.4083] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
447 Kressner M, Bohe M, Cedermark B, Dahlberg M, Damber L, Lindmark G, Öjerskog B, Sjödahl R, Johansson R, Påhlman L. The Impact of Hospital Volume on Surgical Outcome in Patients with Rectal Cancer. Diseases of the Colon & Rectum 2009;52:1542-9. [DOI: 10.1007/dcr.0b013e3181af58f4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
448 Glynne-jones R. Looking for the Good, Bad and the Ugly rectal cancers of the twenty-first century… or “How to avoid tears when peeling onions”. Tech Coloproctol 2017;21:577-9. [DOI: 10.1007/s10151-017-1661-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
449 Hathout L, Maloney-Patel N, Malhotra U, Wang SJ, Chokhavatia S, Dalal I, Poplin E, Jabbour SK. Management of locally advanced rectal cancer in the elderly: a critical review and algorithm. J Gastrointest Oncol 2018;9:363-76. [PMID: 29755777 DOI: 10.21037/jgo.2017.10.10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
450 Bujko K, Partycki M, Pietrzak L. Neoadjuvant Radiotherapy (5 × 5 Gy): Immediate Versus Delayed Surgery. In: Otto F, Lutz MP, editors. Early Gastrointestinal Cancers II: Rectal Cancer. Cham: Springer International Publishing; 2014. pp. 171-87. [DOI: 10.1007/978-3-319-08060-4_12] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
451 Wiltink LM, Marijnen CAM, Meershoek-klein Kranenbarg E, van de Velde CJH, Nout RA. A comprehensive longitudinal overview of health-related quality of life and symptoms after treatment for rectal cancer in the TME trial. Acta Oncologica 2016;55:502-8. [DOI: 10.3109/0284186x.2015.1088171] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
452 Bazarbashi S, Omar A, Aljubran A, Alzahrani A, Alsanea N, Abduljabbar A, Alhomoud S, Ashari L, Balaraj K, Soudy H, Neimatallah M, Fagih M. Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer. Hematol Oncol Stem Cell Ther 2016;9:147-53. [PMID: 27613373 DOI: 10.1016/j.hemonc.2016.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
453 Wei IH, Garcia-Aguilar J. Non-operative management of rectal cancer: understanding tumor biology. Minerva Chir 2018;73:601-18. [PMID: 29795066 DOI: 10.23736/S0026-4733.18.07743-X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
454 Guckenberger M, Wulf J, Thalheimer A, Wehner D, Thiede A, Müller G, Sailer M, Flentje M. Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results. Radiat Oncol 2009;4:67. [PMID: 20025752 DOI: 10.1186/1748-717X-4-67] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
455 Saralegui Y, Enríquez-Navascués JM, Ciria JP, Osorio M, Lacasta A, Elorza G, Garmendia M, Placer C. Results of short term radiotherapy followed by radical surgery for rectal cancer: A long-term unicenter observational study. Cir Esp 2017;95:268-75. [PMID: 28583726 DOI: 10.1016/j.ciresp.2017.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
456 Bach SP, Gilbert A, Brock K, Korsgen S, Geh I, Hill J, Gill T, Hainsworth P, Tutton MG, Khan J, Robinson J, Steward M, Cunningham C, Levy B, Beveridge A, Handley K, Kaur M, Marchevsky N, Magill L, Russell A, Quirke P, West NP, Sebag-Montefiore D;  TREC collaborators. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Lancet Gastroenterol Hepatol. 2021;6:92-105. [PMID: 33308452 DOI: 10.1016/s2468-1253(20)30333-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 14.0] [Reference Citation Analysis]
457 Phang PT, Kennecke H, McGahan CE, Macfarlane J, McGregor G, Hay JH. Predictors of positive radial margin status in a population-based cohort of patients with rectal cancer. Curr Oncol 2008;15:98-103. [PMID: 18454185 DOI: 10.3747/co.v15i2.245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
458 Raldow AC, Chen AB, Russell M, Lee PP, Hong TS, Ryan DP, Cusack JC, Wo JY. Cost-effectiveness of Short-Course Radiation Therapy vs Long-Course Chemoradiation for Locally Advanced Rectal Cancer. JAMA Netw Open. 2019;2:e192249. [PMID: 30977859 DOI: 10.1001/jamanetworkopen.2019.2249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
459 Siegel R, Burock S, Wernecke KD, Kretzschmar A, Dietel M, Loy V, Koswig S, Budach V, Schlag PM. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer. 2009;9:50. [PMID: 19200365 DOI: 10.1186/1471-2407-9-50] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
460 Solanki AA, Chang DT, Liauw SL. Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy. Onco Targets Ther. 2013;6:1097-1110. [PMID: 23983475 DOI: 10.2147/ott.s34869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
461 Breugom AJ, Swets M, Bosset JF, Collette L, Sainato A, Cionini L, Glynne-Jones R, Counsell N, Bastiaannet E, van den Broek CB, Liefers GJ, Putter H, van de Velde CJ. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol. 2015;16:200-207. [PMID: 25589192 DOI: 10.1016/s1470-2045(14)71199-4] [Cited by in Crossref: 298] [Cited by in F6Publishing: 100] [Article Influence: 49.7] [Reference Citation Analysis]
462 Markovina S, Youssef F, Roy A, Aggarwal S, Khwaja S, DeWees T, Tan B, Hunt S, Myerson RJ, Chang DT, Parikh PJ, Olsen JR. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis. Int J Radiat Oncol Biol Phys. 2017;99:417-426. [PMID: 28871992 DOI: 10.1016/j.ijrobp.2017.05.048] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
463 Corrò C, Dutoit V, Koessler T. Emerging Trends for Radio-Immunotherapy in Rectal Cancer. Cancers (Basel) 2021;13:1374. [PMID: 33803620 DOI: 10.3390/cancers13061374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
464 Weiss J, Moghanaki D, Plastaras JP, Haller DG. Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next? Clin Colorectal Cancer 2009;8:194-9. [PMID: 19822509 DOI: 10.3816/CCC.2009.n.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
465 Ahmed S, Eng C. Role of Chemotherapy in the Neoadjuvant/Adjuvant Setting for Patients With Rectal Adenocarcinoma Undergoing Chemoradiotherapy and Surgery or Radiotherapy and Surgery. Curr Oncol Rep 2018;20:3. [PMID: 29362905 DOI: 10.1007/s11912-018-0652-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
466 Sclafani F, Cunningham D. Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer. Future Oncology 2014;10:2243-57. [DOI: 10.2217/fon.14.127] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
467 Krishnamurty DM, Hawkins AT, Wells KO, Mutch MG, Silviera ML, Glasgow SC, Hunt SR, Dharmarajan S. Neoadjuvant Radiation Therapy in Locally Advanced Colon Cancer: a Cohort Analysis. J Gastrointest Surg 2018;22:906-12. [PMID: 29427227 DOI: 10.1007/s11605-018-3676-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
468 Downing A, Glaser AW, Finan PJ, Wright P, Thomas JD, Gilbert A, Corner J, Richards M, Morris EJA, Sebag-Montefiore D. Functional Outcomes and Health-Related Quality of Life After Curative Treatment for Rectal Cancer: A Population-Level Study in England. Int J Radiat Oncol Biol Phys 2019;103:1132-42. [PMID: 30553942 DOI: 10.1016/j.ijrobp.2018.12.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
469 Zhou Z, Liu S, Zhang T, Chen L, Xia J, Hu Z, Li B. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: A systematic review and meta-analysis. Surgical Oncology 2014;23:211-21. [DOI: 10.1016/j.suronc.2014.10.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
470 Hawkes EA, Cunningham D, Tait D, Brown G, Chau I. Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm? Semin Radiat Oncol 2011;21:196-202. [PMID: 21645864 DOI: 10.1016/j.semradonc.2011.02.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
471 Tsukamoto S, Fujita S, Ota M, Mizusawa J, Shida D, Kanemitsu Y, Ito M, Shiomi A, Komori K, Ohue M, Akazai Y, Shiozawa M, Yamaguchi T, Bando H, Tsuchida A, Okamura S, Akagi Y, Takiguchi N, Saida Y, Akasu T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Br J Surg 2020;107:586-94. [PMID: 32162301 DOI: 10.1002/bjs.11513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]
472 Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ; Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693-701. [PMID: 17968156 DOI: 10.1097/01.sla.0000257358.56863.ce] [Cited by in Crossref: 791] [Cited by in F6Publishing: 650] [Article Influence: 56.5] [Reference Citation Analysis]
473 Shin JS, Jalaludin B, Solomon M, Hong A, Lee CS. Histopathological regression grading versus staging of rectal cancer following radiotherapy. Pathology. 2011;43:24-30. [PMID: 21240061 DOI: 10.1097/pat.0b013e328340bb5b] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
474 Trakarnsanga A, Ithimakin S, Weiser MR. Treatment of locally advanced rectal cancer: Controversies and questions. World J Gastroenterol 2012; 18(39): 5521-5532 [PMID: 23112544 DOI: 10.3748/wjg.v18.i39.5521] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
475 Bauman G, Chen J, Rodrigues G, Davidson M, Warner A, Loblaw A. Extreme hypofractionation for high-risk prostate cancer: Dosimetric correlations with rectal bleeding. Pract Radiat Oncol 2017;7:e457-62. [PMID: 28734642 DOI: 10.1016/j.prro.2017.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
476 Ginghină O, Hudiță A, Zaharia C, Tsatsakis A, Mezhuev Y, Costache M, Gălățeanu B. Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients. Materials (Basel) 2021;14:2440. [PMID: 34066710 DOI: 10.3390/ma14092440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
477 Baek S, Kim S, Kwak J, Cho J, Shin J, Amar AHY, Kim J. Selective Use of Preoperative Chemoradiotherapy for T3 Rectal Cancer Can Be Justified: Analysis of Local Recurrence. World J Surg 2013;37:220-6. [DOI: 10.1007/s00268-012-1792-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
478 Nicholls R, Tekkis PP. Multidisciplinary Treatment of Cancer of the Rectum: A European Approach. Surgical Oncology Clinics of North America 2008;17:533-51. [DOI: 10.1016/j.soc.2008.02.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
479 Plastaras JP, Dionisi F, Wo JY. Gastrointestinal cancer: nonliver proton therapy for gastrointestinal cancers. Cancer J 2014;20:378-86. [PMID: 25415682 DOI: 10.1097/PPO.0000000000000085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
480 Huang MY, Huang CW, Wang JY. Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Kaohsiung J Med Sci 2020;36:152-9. [PMID: 31814296 DOI: 10.1002/kjm2.12161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
481 Czito BG, Meyer J. Radiation therapy in anal and rectal cancer. Surg Oncol Clin N Am 2013;22:525-43. [PMID: 23622078 DOI: 10.1016/j.soc.2013.02.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
482 Pucciarelli S, Gagliardi G, Maretto I, Lonardi S, Friso ML, Urso E, Toppan P, Nitti D. Long-Term Oncologic Results and Complications After Preoperative Chemoradiotherapy for Rectal Cancer: A Single-Institution Experience After a Median Follow-Up of 95 Months. Ann Surg Oncol 2009;16:893-9. [DOI: 10.1245/s10434-009-0335-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
483 Chen C, Sun P, Rong J, Weng HW, Dai QS, Ye S. Short Course Radiation in the Treatment of Localized Rectal Cancer: A Systematic Review and Meta-Analysis. Sci Rep 2015;5:10953. [PMID: 26055266 DOI: 10.1038/srep10953] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
484 Fernandez-Martos C, Guerrero A, Minsky B. Clinically relevant study end points in rectal cancer. Recent Results Cancer Res 2012;196:3-19. [PMID: 23129363 DOI: 10.1007/978-3-642-31629-6_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
485 Habr-gama A, Gama-rodrigues J, Perez RO. Is Tailoring Treatment of Rectal Cancer the Only True Benefit of Long-Course Neoadjuvant Chemoradiation? Diseases of the Colon & Rectum 2013;56:264-6. [DOI: 10.1097/dcr.0b013e318277e8e4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
486 Avallone A, Piccirillo MC, Delrio P, Pecori B, Di Gennaro E, Aloj L, Tatangelo F, D'Angelo V, Granata C, Cavalcanti E, Maurea N, Maiolino P, Bianco F, Montano M, Silvestro L, Terranova Barberio M, Roca MS, Di Maio M, Marone P, Botti G, Petrillo A, Daniele G, Lastoria S, Iaffaioli VR, Romano G, Caracò C, Muto P, Gallo C, Perrone F, Budillon A. Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial). BMC Cancer 2014;14:875. [PMID: 25421252 DOI: 10.1186/1471-2407-14-875] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
487 Glynne-Jones R, Kronfli M. Locally advanced rectal cancer: a comparison of management strategies. Drugs. 2011;71:1153-1177. [PMID: 21711061 DOI: 10.2165/11591330-000000000-00000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
488 Yamashita H, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Okuma K, Abe O, Watanabe T, Nakagawa K. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Radiat Oncol 2017;12. [DOI: 10.1186/s13014-017-0894-9] [Reference Citation Analysis]
489 Valadão M, Cesar D, Véo CAR, Araújo RO, do Espirito Santo GF, Oliveira de Souza R, Aguiar S Jr, Ribeiro R, de Castro Ribeiro HS, de Souza Fernandes PH, Oliveira AF. Brazilian society of surgical oncology: Guidelines for the surgical treatment of mid-low rectal cancer. J Surg Oncol 2021. [PMID: 34585390 DOI: 10.1002/jso.26676] [Reference Citation Analysis]
490 Sirák I, Pohanková D, Ferko A, Hovorková E, Rozkoš T, Vošmik M, Hodek M, Paluska P, Buka D, Grepl J, Petera J. The Time Between Chemoradiation and Surgery for Rectal Carcinoma Negatively Influences Mesorectal Excision Quality. Pathol Oncol Res 2020;26:1565-72. [PMID: 31482400 DOI: 10.1007/s12253-019-00742-w] [Reference Citation Analysis]
491 Avallone A, Delrio P, Lastoria S, Comella P. Chemo-radiotherapy in locally advanced rectal cancer: What is the optimal strategy? European Journal of Cancer Supplements 2008;6:70-3. [DOI: 10.1016/j.ejcsup.2008.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
492 Abdel-Rahman O, Kumar A, Kennecke HF, Speers CH, Cheung WY. Impact of Duration of Neoadjuvant Radiation on Rectal Cancer Survival: A Real World Multi-center Retrospective Cohort Study. Clin Colorectal Cancer 2018;17:e21-8. [PMID: 28709877 DOI: 10.1016/j.clcc.2017.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
493 Ishii Y, Hasegawa H, Endo T, Okabayashi K, Ochiai H, Moritani K, Watanabe M, Kitagawa Y. Medium-term results of neoadjuvant systemic chemotherapy using irinotecan, 5-fluorouracil, and leucovorin in patients with locally advanced rectal cancer. Eur J Surg Oncol. 2010;36:1061-1065. [PMID: 20538422 DOI: 10.1016/j.ejso.2010.05.017] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
494 Latkauskas T, Paskauskas S, Dambrauskas Z, Gudaityte J, Saladzinskas S, Tamelis A, Pavalkis D. Preoperative chemoradiation vs radiation alone for stage II and III resectable rectal cancer: a meta-analysis. Colorectal Dis 2010;12:1075-83. [PMID: 19624519 DOI: 10.1111/j.1463-1318.2009.02015.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
495 Wong CS, Chu W, Ashamalla S, Fenech D, Berry S, Kiss A, Koritzinsky M. Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial. Clin Transl Radiat Oncol 2021;30:60-4. [PMID: 34401534 DOI: 10.1016/j.ctro.2021.07.001] [Reference Citation Analysis]
496 Pauzas H, Gyvyte U, Latkauskas T, Kairevice L, Lizdenis P, Svagzdys S, Birgiolaite E, Kuliaviene I, Kupcinskas J, Tamelis A. The Role of VEGFA, COX2, HUR and CUGBP2 in Predicting the Response to Neoadjuvant Therapy in Rectal Cancer Patients. Medicina (Kaunas) 2020;56:E192. [PMID: 32331433 DOI: 10.3390/medicina56040192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
497 Gilbert A, Ziegler L, Martland M, Davidson S, Efficace F, Sebag-montefiore D, Velikova G. Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting. International Journal of Radiation Oncology*Biology*Physics 2015;92:555-67. [DOI: 10.1016/j.ijrobp.2015.02.021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
498 Glynne-jones R, Hughes R. Complete Response after Chemoradiotherapy in Rectal Cancer (Watch-and-Wait): Have we Cracked the Code? Clinical Oncology 2016;28:152-60. [DOI: 10.1016/j.clon.2015.10.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
499 Fitzgerald TL, Brinkley J, Zervos EE. Pushing the Envelope Beyond a Centimeter in Rectal Cancer: Oncologic Implications of Close, But Negative Margins. Journal of the American College of Surgeons 2011;213:589-95. [DOI: 10.1016/j.jamcollsurg.2011.07.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
500 Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2009;CD006041. [PMID: 19160264 DOI: 10.1002/14651858.cd006041.pub2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
501 Restivo A, Cocco IM, Casula G, Scintu F, Cabras F, Scartozzi M, Zorcolo L. Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer. Br J Cancer 2015;113:1133-9. [PMID: 26372700 DOI: 10.1038/bjc.2015.336] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
502 Jankowski M, Bała D, Las-Jankowska M, Wysocki WM, Nowikiewicz T, Zegarski W. Overall treatment outcome - analysis of long-term results of rectal cancer treatment on the basis of a new parameter. Arch Med Sci 2020;16:825-33. [PMID: 32542084 DOI: 10.5114/aoms.2020.94330] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
503 Joye I, Haustermans K. Early and late toxicity of radiotherapy for rectal cancer. Recent Results Cancer Res 2014;203:189-201. [PMID: 25103006 DOI: 10.1007/978-3-319-08060-4_13] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
504 Erlandsson J, Lörinc E, Ahlberg M, Pettersson D, Holm T, Glimelius B, Martling A. Tumour regression after radiotherapy for rectal cancer – Results from the randomised Stockholm III trial. Radiotherapy and Oncology 2019;135:178-86. [DOI: 10.1016/j.radonc.2019.03.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
505 Dewdney A, Cunningham D, Chau I. Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies. Oncologist. 2013;18:833-842. [PMID: 23821325 DOI: 10.1634/theoncologist.2013-0022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
506 Derbel O, Wang Q, Desseigne F, Rivoire M, Meeus P, Peyrat P, Stella M, Martel-Lafay I, Lemaistre AI, de La Fouchardière C. Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery. BMC Cancer 2013;13:200. [PMID: 23617638 DOI: 10.1186/1471-2407-13-200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
507 Habr-Gama A, São Julião GP, Perez RO. Nonoperative management of rectal cancer: identifying the ideal patients. Hematol Oncol Clin North Am 2015;29:135-51. [PMID: 25475576 DOI: 10.1016/j.hoc.2014.09.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
508 Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D; ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28:iv22-40. [PMID: 28881920 DOI: 10.1093/annonc/mdx224] [Cited by in Crossref: 477] [Cited by in F6Publishing: 416] [Article Influence: 159.0] [Reference Citation Analysis]
509 Enker WE. The Natural History of Rectal Cancer 1908-2008: The Evolving Treatment of Rectal Cancer into the Twenty-First Century. Seminars in Colon and Rectal Surgery 2010;21:56-74. [DOI: 10.1053/j.scrs.2010.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
510 Watanabe T. Chemoradiotherapy and adjuvant chemotherapy for rectal cancer. Int J Clin Oncol. 2008;13:488-497. [PMID: 19093175 DOI: 10.1007/s10147-008-0849-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
511 Kwaan MR. Bowel Function After Rectal Cancer Surgery: A Review of the Evidence. Seminars in Colon and Rectal Surgery 2011;22:235-42. [DOI: 10.1053/j.scrs.2011.06.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
512 Lefevre JH, Mineur L, Kotti S, Rullier E, Rouanet P, de Chaisemartin C, Meunier B, Mehrdad J, Cotte E, Desrame J, Karoui M, Benoist S, Kirzin S, Berger A, Panis Y, Piessen G, Saudemont A, Prudhomme M, Peschaud F, Dubois A, Loriau J, Tuech JJ, Meurette G, Lupinacci R, Goasgen N, Parc Y, Simon T, Tiret E. Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6). J Clin Oncol. 2016;34:3773-3780. [PMID: 27432930 DOI: 10.1200/jco.2016.67.6049] [Cited by in Crossref: 221] [Cited by in F6Publishing: 82] [Article Influence: 55.3] [Reference Citation Analysis]
513 Body A, Prenen H, Lam M, Davies A, Tipping-Smith S, Lum C, Liow E, Segelov E. Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Recent Advances and Ongoing Challenges. Clin Colorectal Cancer 2021;20:29-41. [PMID: 33531256 DOI: 10.1016/j.clcc.2020.12.005] [Reference Citation Analysis]
514 Russo S, Steele S, Fredman E, Biswas T. Current topics in the multimodality treatment of locally advanced rectal cancer. Future Oncol 2016;12:963-79. [PMID: 26880222 DOI: 10.2217/fon.16.12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
515 Margalit O, Mamtani R, Lawrence YR, Yang YX, Baruch EN, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B. Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent? Mol Clin Oncol 2019;10:555-9. [PMID: 30967950 DOI: 10.3892/mco.2019.1825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
516 Brown KGM, Solomon MJ, Mahon K, O’shannassy S. Management of colorectal cancer. BMJ. [DOI: 10.1136/bmj.l4561] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
517 Wu H, Fang C, Huang L, Fan C, Wang C, Yang L, Li Y, Zhou Z. Short-course radiotherapy with immediate or delayed surgery in rectal cancer: A meta-analysis. Int J Surg 2018;56:195-202. [PMID: 29807169 DOI: 10.1016/j.ijsu.2018.05.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
518 Ryan ÉJ, O'Sullivan DP, Kelly ME, Syed AZ, Neary PC, O'Connell PR, Kavanagh DO, Winter DC, O'Riordan JM. Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer. Br J Surg 2019;106:1298-310. [PMID: 31216064 DOI: 10.1002/bjs.11220] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
519 Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29:3163-3172. [PMID: 21747092 DOI: 10.1200/jco.2010.33.1595] [Cited by in Crossref: 288] [Cited by in F6Publishing: 134] [Article Influence: 28.8] [Reference Citation Analysis]
520 Idasiak A, Galwas-Kliber K, Behrendt K, Wziętek I, Kryj M, Stobiecka E, Chmielik E, Suwiński R. Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study. Br J Radiol 2017;90:20160731. [PMID: 28466686 DOI: 10.1259/bjr.20160731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
521 Zhang MX, Li XB, Guan BJ, Guan GX, Lin XY, Wu XD, Chi P, Xu BH. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial. BMJ Open 2019;9:e025944. [PMID: 30904869 DOI: 10.1136/bmjopen-2018-025944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
522 Kaidar-Person O, Roach M 3rd, Créhange G. Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward. Int J Radiat Oncol Biol Phys 2013;86:600-5. [PMID: 23523182 DOI: 10.1016/j.ijrobp.2013.02.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
523 Fernandez-martos C, Fadrique AG, Glynne-jones R. Optimal Sequencing of Neoadjuvant Therapies (NAT) in Rectal Cancer: Upfront Chemotherapy vs. Upfront Chemoradiation. Curr Colorectal Cancer Rep 2017;13:154-64. [DOI: 10.1007/s11888-017-0358-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
524 Kavanagh BD, Miften M, Rabinovitch RA. Advances in Treatment Techniques: Stereotactic Body Radiation Therapy and the Spread of Hypofractionation. The Cancer Journal 2011;17:177-81. [DOI: 10.1097/ppo.0b013e31821f7dbd] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
525 Mulsow J, Winter DC. Sphincter preservation for distal rectal cancer - a goal worth achieving at all costs? World J Gastroenterol 2011; 17(7): 855-861 [PMID: 21412495 DOI: 10.3748/wjg.v17.i7.855] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
526 Martijn H, Vulto J. Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer? European Journal of Cancer 2007;43:2301-6. [DOI: 10.1016/j.ejca.2007.06.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
527 Glimelius B. Neo-adjuvant radiotherapy in rectal cancer. World J Gastroenterol 2013; 19(46): 8489-8501 [PMID: 24379566 DOI: 10.3748/wjg.v19.i46.8489] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
528 Birgisson H, Påhlman L, Gunnarsson U, Glimelius B. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 2008;95:206-13. [PMID: 17849380 DOI: 10.1002/bjs.5918] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
529 Suppiah A, Hartley JE, Monson JR. Advances in radiotherapy in operable rectal cancer. Dig Surg 2009;26:187-99. [PMID: 19494494 DOI: 10.1159/000219931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
530 Bulajic P, Bidzic N, Djordjevic V, Ceranic Μ, Βasaric D, Pesic V, Djordjevic-Pesic J. Impact of Genetics on Neoadjuvant Therapy with Complete Pathological Response in Metastatic Colorectal Cancer: Case Report and Review of the Literature. Balkan J Med Genet 2019;22:75-80. [PMID: 31523624 DOI: 10.2478/bjmg-2019-0004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-820. [PMID: 19269519 DOI: 10.1016/s0140-6736(09)60484-0] [Cited by in Crossref: 969] [Cited by in F6Publishing: 317] [Article Influence: 80.8] [Reference Citation Analysis]
532 Zeestraten EC, Kuppen PJ, van de Velde CJ, Marijnen CA. Prediction in rectal cancer. Semin Radiat Oncol. 2012;22:175-183. [PMID: 22385923 DOI: 10.1016/j.semradonc.2011.12.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
533 Kim J, Kim J, Liang ZL, Jang JY, Kim S, Huh GJ, Kim K, Cho M. Prognostic Significance of Human Apurinic/Apyrimidinic Endonuclease (APE/Ref-1) Expression in Rectal Cancer Treated With Preoperative Radiochemotherapy. International Journal of Radiation Oncology*Biology*Physics 2012;82:130-7. [DOI: 10.1016/j.ijrobp.2010.09.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
534 Zampino MG, Magni E, Leonardi MC, Petazzi E, Santoro L, Luca F, Chiappa A, Petralia G, Trovato C, Fazio N, Orecchia R, Nolè F, de Braud F. Capecitabine Initially Concomitant to Radiotherapy Then Perioperatively Administered in Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 2009;75:421-7. [DOI: 10.1016/j.ijrobp.2008.11.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
535 Wang SJ, Hathout L, Malhotra U, Maloney-Patel N, Kilic S, Poplin E, Jabbour SK. Decision-Making Strategy for Rectal Cancer Management Using Radiation Therapy for Elderly or Comorbid Patients. Int J Radiat Oncol Biol Phys. 2018;100:926-944. [PMID: 29485072 DOI: 10.1016/j.ijrobp.2017.12.261] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
536 Liveringhouse C, Sim A, Yamoah K, Poch M, Wilder RB, Pow-Sang J, Johnstone PAS. Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer. Rep Pract Oncol Radiother 2021;26:188-95. [PMID: 34211768 DOI: 10.5603/RPOR.a2021.0027] [Reference Citation Analysis]
537 Willett C, Czito B. Chemoradiotherapy in Gastrointestinal Malignancies. Clinical Oncology 2009;21:543-56. [DOI: 10.1016/j.clon.2009.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
538 van Gijn W, van de Velde CJ. 2010 SSO John Wayne clinical research lecture: rectal cancer outcome improvements in Europe: population-based outcome registrations will conquer the world. Ann Surg Oncol. 2011;18:691-696. [PMID: 20844966 DOI: 10.1245/s10434-010-1326-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
539 Buccafusca G, Proserpio I, Tralongo AC, Rametta Giuliano S, Tralongo P. Early colorectal cancer: diagnosis, treatment and survivorship care. Crit Rev Oncol Hematol 2019;136:20-30. [PMID: 30878125 DOI: 10.1016/j.critrevonc.2019.01.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
540 Ngan SY. Preoperative Treatment of Locally Advanced Rectal Cancer: Assets and Drawbacks of Short Course and Long Course in Clinical Practice. Seminars in Radiation Oncology 2016;26:186-92. [DOI: 10.1016/j.semradonc.2016.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
541 Yoon HI, Koom WS, Kim TH, Ahn JB, Jung M, Kim TI, Kim H, Shin SJ, Kim NK. Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors. PLoS One 2016;11:e0161475. [PMID: 27536871 DOI: 10.1371/journal.pone.0161475] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
542 Díaz Beveridge R, Akhoundova D, Bruixola G, Aparicio J. Controversies in the multimodality management of locally advanced rectal cancer. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-0964-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
543 Kawai K, Ishihara S, Nozawa H, Hata K, Kiyomatsu T, Tanaka T, Nishikawa T, Otani K, Yasuda K, Murono K, Sasaki K, Watanabe T. Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer. J Anus Rectum Colon 2017;1:39-44. [PMID: 31583299 DOI: 10.23922/jarc.2017-005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
544 Huang CW, Su WC, Yin TC, Chen PJ, Chang TK, Chen YC, Li CC, Hsieh YC, Tsai HL, Wang JY. Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapy. PLoS One 2020;15:e0240742. [PMID: 33064768 DOI: 10.1371/journal.pone.0240742] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
545 Doornebosch PG, Tollenaar RA, De Graaf EJ. Is the increasing role of Transanal Endoscopic Microsurgery in curation for T1 rectal cancer justified? A systematic review. Acta Oncol. 2009;48:343-353. [PMID: 18855161 DOI: 10.1080/02841860802342408] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
546 Glynne-Jones R, Harrison M, Hughes R. Challenges in the neoadjuvant treatment of rectal cancer: balancing the risk of recurrence and quality of life. Cancer Radiother 2013;17:675-85. [PMID: 24183502 DOI: 10.1016/j.canrad.2013.06.043] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
547 Roeder F, Meldolesi E, Gerum S, Valentini V, Rödel C. Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review. Radiat Oncol 2020;15:262. [PMID: 33172475 DOI: 10.1186/s13014-020-01695-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
548 Ulrich AB, Seiler C, Rahbari N, Weitz J, Büchler MW. Diverting stoma after low anterior resection: more arguments in favor. Dis Colon Rectum. 2009;52:412-418. [PMID: 19333040 DOI: 10.1007/dcr.0b013e318197e1b1] [Cited by in Crossref: 86] [Cited by in F6Publishing: 25] [Article Influence: 7.2] [Reference Citation Analysis]
549 Hüttner FJ, Probst P, Kalkum E, Hackbusch M, Jensen K, Ulrich A, Debus J, Jäger D, Diener MK. Addition of Platinum Derivatives to Fluoropyrimidine-Based Neoadjuvant Chemoradiotherapy for Stage II/III Rectal Cancer: Systematic Review and Meta-Analysis. J Natl Cancer Inst 2019;111:887-902. [PMID: 31077329 DOI: 10.1093/jnci/djz081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
550 Chen Z, Li S, Wang Y, Fu Z, Liu N, Wang H, Liu X. Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study. Front Oncol 2020;10:584835. [PMID: 33363014 DOI: 10.3389/fonc.2020.584835] [Reference Citation Analysis]
551 Manur JG, Patel RB, Chandramouli S. Efficacy of preoperative chemoradiotherapy in downstaging rectal cancer and its impact on the long-term outcome. South Asian J Cancer 2019;8:98-101. [PMID: 31069187 DOI: 10.4103/sajc.sajc_203_17] [Reference Citation Analysis]
552 Fiore M, Greco C, Coppola A, Caricato M, Caputo D, Trecca P, Floreno B, Rinaldi CG, Ippolito E, Capolupo GT, Grippo R, Beomonte Zobel B, D'Angelillo RM, Trodella L, Ramella S. Long-Term Results of a Prospective Phase 2 Study on Volume De-Escalation in Neoadjuvant Chemoradiotherapy of Rectal Cancer. Pract Radiat Oncol 2021;11:e186-94. [PMID: 33002647 DOI: 10.1016/j.prro.2020.09.009] [Reference Citation Analysis]
553 Uehara K, Nagino M. Neoadjuvant treatment for locally advanced rectal cancer: a systematic review. Surg Today 2016;46:161-8. [PMID: 26170102 DOI: 10.1007/s00595-015-1218-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
554 Coyle Y. Adjuvant and Neoadjuvant Therapy for Colorectal Cancer. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. Elsevier; 2019. pp. 2126-36. [DOI: 10.1016/b978-0-323-40232-3.00176-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
555 Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clin Colorectal Cancer 2020;19:116-22. [PMID: 32173279 DOI: 10.1016/j.clcc.2020.02.005] [Reference Citation Analysis]
556 Tural D, Selcukbiricik F, Yıldız Ö, Elcin O, Erdamar S, Güney S, Demireli F, Büyükünal E, Serdengeçti S. Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer. Int J Clin Oncol 2014;19:889-96. [PMID: 24218281 DOI: 10.1007/s10147-013-0636-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
557 Lee JH, Jang HS, Kim JG, Lee MA, Kim DY, Kim TH, Oh JH, Park SC, Kim SY, Baek JY, Park HC, Kim HC, Nam TK, Chie EK, Jung JH, Oh ST. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02. Radiother Oncol 2014;113:18-23. [PMID: 25245559 DOI: 10.1016/j.radonc.2014.08.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
558 Liu S, Jiang T, Xiao L, Yang S, Liu Q, Gao Y, Chen G, Xiao W. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis. Oncologist 2021;26:e1555-66. [PMID: 33987952 DOI: 10.1002/onco.13824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
559 Ikeda M, Sekimoto M, Fukunaga Y, Konishi K, Fujiwara Y, Mizushima T, Takemasa I, Yamamoto H, Doki Y, Mori M. A phase I study of oral UFT/leucovorin and irinotecan, plus radiation for locally recurrent rectal cancer. J Anus Rectum Colon 2017;1:50-5. [PMID: 31583301 DOI: 10.23922/jarc.2016-009] [Reference Citation Analysis]
560 Honda M, Akiyoshi T, Noma H, Ogura A, Nagasaki T, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Ueno M. Patient-centered outcomes to decide treatment strategy for patients with low rectal cancer. J Surg Oncol 2016;114:630-6. [PMID: 27761895 DOI: 10.1002/jso.24376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
561 Wang BL, Jiang W, Du SS, Xu JM, Zeng ZC. The therapeutic and adverse effects of modified radiation fields for patients with rectal cancer. Clin Colorectal Cancer 2012;11:255-62. [PMID: 22763195 DOI: 10.1016/j.clcc.2012.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
562 Mallick S, Benson R, Haresh K, Rath G. Neoadjuvant treatment intensification or adjuvant chemotherapy for locally advanced carcinoma rectum: The optimum treatment approach remains unresolved. Journal of the Egyptian National Cancer Institute 2015;27:179-85. [DOI: 10.1016/j.jnci.2015.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
563 Pomerri F, Maretto I, Pucciarelli S, Rugge M, Burzi S, Zandonà M, Ambrosi A, Urso E, Muzzio PC, Nitti D. Prediction of rectal lymph node metastasis by pelvic computed tomography measurement. Eur J Surg Oncol 2009;35:168-73. [PMID: 18359603 DOI: 10.1016/j.ejso.2008.02.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
564 Wo JY, Hong TS, Kachnic LA. Impact of Age and Comorbidities on the Treatment of Gastrointestinal Malignancies. Seminars in Radiation Oncology 2012;22:311-20. [DOI: 10.1016/j.semradonc.2012.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
565 Bach SP. Developments in early rectal cancer treatment. European Journal of Cancer 2009;45:464-5. [DOI: 10.1016/s0959-8049(09)70091-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
566 Massarweh NN, Artinyan A, Chang GJ. Neoadjuvant treatment for rectal cancer-A value-based proposition: Neoadjuvant Rectal Cancer Treatment. J Surg Oncol 2016;114:304-10. [DOI: 10.1002/jso.24267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
567 Guckenberger M, Saur G, Wehner D, Thalheimer A, Kim M, Germer C, Flentje M. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Radiotherapy and Oncology 2013;108:326-30. [DOI: 10.1016/j.radonc.2013.08.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
568 Loftås P, Arbman G, Fomichov V, Hallböök O. Nodal involvement in luminal complete response after neoadjuvant treatment for rectal cancer. Eur J Surg Oncol 2016;42:801-7. [PMID: 27146960 DOI: 10.1016/j.ejso.2016.03.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
569 Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2009;124:CD006041. [PMID: 19160264 DOI: 10.1002/ijc.24247] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
570 Tseng M, Soon YY, Vellayappan B, Ho F, Tey J. Radiation therapy for rectal cancer. J Gastrointest Oncol 2019;10:1238-50. [PMID: 31949945 DOI: 10.21037/jgo.2018.12.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
571 Koike J, Funahashi K, Yoshimatsu K, Yokomizo H, Kan H, Yamada T, Ishida H, Ishibashi K, Saida Y, Enomoto T, Katsumata K, Hisada M, Hasegawa H, Koda K, Ochiai T, Sakamoto K, Shiokawa H, Ogawa S, Itabashi M, Kameoka S. Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial. Cancer Chemother Pharmacol. 2017;79:519-525. [PMID: 28150022 DOI: 10.1007/s00280-017-3243-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
572 van Rees JM, Höppener DJ, Hagemans JAW, Rothbarth J, Grünhagen DJ, Nuyttens JJME, van Meerten E, de Vries M, Verhoef C. The clinical relevance of indeterminate lung nodules in patients with locally recurrent rectal cancer. Eur J Surg Oncol 2021;47:1616-22. [PMID: 33446352 DOI: 10.1016/j.ejso.2020.12.013] [Reference Citation Analysis]
573 Goodman KA, Patton CE, Fisher GA, Hoffe SE, Haddock MG, Parikh PJ, Kim J, Baxter NN, Czito BG, Hong TS, Herman JM, Crane CH, Hoffman KE. Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness Method. Practical Radiation Oncology 2016;6:166-75. [DOI: 10.1016/j.prro.2015.11.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
574 Beppu N, Yanagi H, Tomita N. A review of preoperative chemoradiotherapy for lower rectal cancer. J Anus Rectum Colon 2017;1:65-73. [PMID: 31583303 DOI: 10.23922/jarc.2017-013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
575 De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, Izzo P, Delrio P. Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015;34:1087-1096. [PMID: 26151224 DOI: 10.3892/or.2015.4108] [Cited by in Crossref: 141] [Cited by in F6Publishing: 143] [Article Influence: 23.5] [Reference Citation Analysis]
576 Sajid MS, Siddiqui MRS, Kianifard B, Baig MK. Short-course versus long-course neoadjuvant radiotherapy for lower rectal cancer: a systematic review. Ir J Med Sci 2010;179:165-71. [DOI: 10.1007/s11845-009-0382-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
577 Kennedy ED, Schmocker S, Victor C, Baxter NN, Kim J, Brierley J, McLeod RS. Do patients consider preoperative chemoradiation for primary rectal cancer worthwhile? Cancer 2011;117:2853-62. [PMID: 21692046 DOI: 10.1002/cncr.25842] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
578 Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Colorectal cancer. Lancet. 2010;375:1030-1047. [PMID: 20304247 DOI: 10.1016/s0140-6736(10)60353-4] [Cited by in Crossref: 1026] [Cited by in F6Publishing: 586] [Article Influence: 93.3] [Reference Citation Analysis]
579 Bernier L, Balyasnikova S, Tait D, Brown G. Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer. Curr Colorectal Cancer Rep. 2018;14:37-55. [PMID: 29576755 DOI: 10.1007/s11888-018-0398-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
580 Glynne-Jones R, Mathur P, Elton C, Train ML. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer. Best Pract Res Clin Gastroenterol. 2007;21:1049-1070. [PMID: 18070703 DOI: 10.1016/j.bpg.2007.11.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
581 Alawawdeh A, Krishnan T, Roy A, Karapetis C, Joshi R, Singhal N, Price T. Curative therapy for rectal cancer. Expert Rev Anticancer Ther 2021;21:193-203. [PMID: 33161803 DOI: 10.1080/14737140.2021.1845145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
582 Gerard JP, Rostom Y, Gal J, Benchimol D, Ortholan C, Aschele C, Levi JM. Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials. Crit Rev Oncol Hematol. 2012;81:21-28. [PMID: 21377377 DOI: 10.1016/j.critrevonc.2011.02.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
583 van der Voort van Zyp JR, Ceha HM, Niehe V, Marinelli AW, Putter H, Marijnen CA. Acute toxicity after a diverting stoma and spacer prior to chemoradiation in locally advanced rectal cancer. Radiother Oncol. 2015;116:107-111. [PMID: 26187017 DOI: 10.1016/j.radonc.2015.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
584 Wiltink LM, Nout RA, van der Voort van Zyp JR, Ceha HM, Fiocco M, Meershoek-klein Kranenbarg E, Marinelli AW, van de Velde CJ, Marijnen CA. Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy. Clinical Colorectal Cancer 2016;15:e93-9. [DOI: 10.1016/j.clcc.2016.02.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
585 Ling DC, Vargo JA, Beriwal S. Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care? Int J Radiat Oncol Biol Phys 2020;108:390-3. [PMID: 32890517 DOI: 10.1016/j.ijrobp.2020.06.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
586 Rectal Cancer Alliance Of Canada (RCAC)., Rectal Cancer Alliance Of Canada RCAC. QuickSilver: A Phase II Study Using Magnetic Resonance Imaging Criteria to Identify "Good Prognosis" Rectal Cancer Patients Eligible for Primary Surgery. JMIR Res Protoc 2015;4:e41. [PMID: 25871328 DOI: 10.2196/resprot.4151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
587 Watanabe T, Muro K, Ajioka Y, Hashiguchi Y, Ito Y, Saito Y, Hamaguchi T, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kawano H, Kinugasa Y, Kokudo N, Murofushi K, Nakajima T, Oka S, Sakai Y, Tsuji A, Uehara K, Ueno H, Yamazaki K, Yoshida M, Yoshino T, Boku N, Fujimori T, Itabashi M, Koinuma N, Morita T, Nishimura G, Sakata Y, Shimada Y, Takahashi K, Tanaka S, Tsuruta O, Yamaguchi T, Yamaguchi N, Tanaka T, Kotake K, Sugihara K;  Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23:1-34. [PMID: 28349281 DOI: 10.1007/s10147-017-1101-6] [Cited by in Crossref: 400] [Cited by in F6Publishing: 371] [Article Influence: 100.0] [Reference Citation Analysis]
588 Moser L, Ritz J, Hinkelbein W, Höcht S. Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer—a review focusing on open questions. Int J Colorectal Dis 2008;23:227-36. [DOI: 10.1007/s00384-007-0419-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
589 Hattori N, Nakayama G, Uehara K, Aiba T, Ishigure K, Sakamoto E, Tojima Y, Kanda M, Kobayashi D, Tanaka C, Yamada S, Koike M, Fujiwara M, Nagino M, Kodera Y. Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II). Int J Clin Oncol 2020;25:118-25. [PMID: 31542847 DOI: 10.1007/s10147-019-01546-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
590 Dayal S, Moran B. LOREC: the English Low Rectal Cancer National Development Programme. British Journal of Hospital Medicine 2013;74:377-80. [DOI: 10.12968/hmed.2013.74.7.377] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
591 Murimwa G, Hester C, Mansour JC, Polanco PM, Porembka MR, Wang SC, Zeh HJ Jr, Yopp AC. Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database. J Gastrointest Surg 2021;25:1815-27. [PMID: 32705618 DOI: 10.1007/s11605-020-04729-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
592 van der Valk MJM, Marijnen CAM, van Etten B, Dijkstra EA, Hilling DE, Kranenbarg EM, Putter H, Roodvoets AGH, Bahadoer RR, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes AMR, de Groot DJA, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP; Collaborative investigators. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial. Radiother Oncol. 2020;147:75-83. [PMID: 32240909 DOI: 10.1016/j.radonc.2020.03.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 45.0] [Reference Citation Analysis]
593 Glynne-Jones R, Hughes R. Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg. 2012;99:897-909. [PMID: 22539154 DOI: 10.1002/bjs.8732] [Cited by in Crossref: 169] [Cited by in F6Publishing: 125] [Article Influence: 18.8] [Reference Citation Analysis]
594 Wang L, Zhai ZW, Ji DB, Li ZW, Gu J. Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy. Int J Colorectal Dis 2015;30:753-60. [PMID: 25935450 DOI: 10.1007/s00384-015-2226-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
595 Curigliano G, Banerjee S, Cervantes A, Garassino MC, Garrido P, Girard N, Haanen J, Jordan K, Lordick F, Machiels JP, Michielin O, Peters S, Tabernero J, Douillard JY, Pentheroudakis G; Panel members. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol 2020;31:1320-35. [PMID: 32745693 DOI: 10.1016/j.annonc.2020.07.010] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 73.0] [Reference Citation Analysis]
596 Rijkmans E, van Triest B, Nout R, Kerkhof E, Buijsen J, Rozema T, Franssen J, Velema L, Laman M, Cats A, Marijnen C. Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study. Radiotherapy and Oncology 2018;126:417-23. [DOI: 10.1016/j.radonc.2017.12.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
597 Ansari N, Solomon MJ, Fisher RJ, Mackay J, Burmeister B, Ackland S, Heriot A, Joseph D, McLachlan SA, McClure B, Ngan SY. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04). Ann Surg. 2017;265:882-888. [PMID: 27631775 DOI: 10.1097/sla.0000000000001987] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 9.8] [Reference Citation Analysis]
598 Zwirner K, Bonomo P, Lamprecht U, Zips D, Gani C. External validation of a rectal cancer outcome prediction model with a cohort of patients treated with preoperative radiochemotherapy and deep regional hyperthermia. International Journal of Hyperthermia 2018;34:455-60. [DOI: 10.1080/02656736.2017.1338364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
599 Valentini V, Glimelius B, Haustermans K, Marijnen CA, Rödel C, Gambacorta MA, Boelens PG, Aristei C, van de Velde CJ. EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist’s expert review. Radiother Oncol. 2014;110:195-198. [PMID: 24286634 DOI: 10.1016/j.radonc.2013.10.024] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
600 Cui J, Fang H, Zhang L, Wu YL, Zhang HZ. Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy. Chronic Dis Transl Med 2016;2:10-6. [PMID: 29063019 DOI: 10.1016/j.cdtm.2016.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
601 Thompson MK, Poortmans P, Chalmers AJ, Faivre-Finn C, Hall E, Huddart RA, Lievens Y, Sebag-Montefiore D, Coles CE. Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? Br J Cancer 2018;119:389-407. [PMID: 30061587 DOI: 10.1038/s41416-018-0201-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
602 Yamashita H, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Okuma K, Abe O, Watanabe T, Nakagawa K. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Radiat Oncol 2017;12:156. [PMID: 28934968 DOI: 10.1186/s13014-017-0894-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
603 Couwenberg AM, Burbach JPM, Intven MPW, Consten ECJ, Schiphorst AHW, Smits AB, Wijffels NAT, Heikens JT, Koopman M, van Grevenstein WMU, Verkooijen HM. Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery: a propensity score-matched cohort study. Acta Oncologica 2019;58:407-16. [DOI: 10.1080/0284186x.2018.1551622] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
604 Cambray M, Gonzalez-Viguera J, Berenguer MA, Macià M, Losa F, Soler G, Frago R, Castellví J, Guinó E. Short-Course Radiotherapy in Locally Advanced Rectal Cancer. Clin Transl Gastroenterol 2020;11:e00162. [PMID: 32568477 DOI: 10.14309/ctg.0000000000000162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
605 Minsky BD. Unique considerations in the patient with rectal cancer. Semin Oncol 2011;38:542-51. [PMID: 21810513 DOI: 10.1053/j.seminoncol.2011.05.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
606 Kim H, Pedersen K, Olsen JR, Mutch MG, Chin RI, Glasgow SC, Wise PE, Silviera ML, Tan BR, Wang-Gillam A, Lim KH, Suresh R, Amin M, Huang Y, Henke LE, Park H, Ciorba MA, Badiyan S, Parikh PJ, Roach MC, Hunt SR. Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial. Clin Colorectal Cancer 2021;20:e185-93. [PMID: 34001462 DOI: 10.1016/j.clcc.2021.03.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
607 Wang X, Qiu A, Liu X, Shi Y. Total mesorectal excision plus lateral lymph node dissection vs TME on rectal cancer patients: a meta-analysis.Int J Colorectal Dis. 2020;35:997-1006. [PMID: 32356120 DOI: 10.1007/s00384-020-03610-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
608 Deschner BW, VanderWalde NA, Grothey A, Shibata D. Evolution and Current Status of the Multidisciplinary Management of Locally Advanced Rectal Cancer. JCO Oncol Pract 2021;17:383-402. [PMID: 33881906 DOI: 10.1200/OP.20.00885] [Reference Citation Analysis]
609 Doi H, Yokoyama H, Beppu N, Fujiwara M, Harui S, Kakuno A, Yanagi H, Hishikawa Y, Yamanaka N, Kamikonya N. Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer. Cancers (Basel) 2021;13:4112. [PMID: 34439265 DOI: 10.3390/cancers13164112] [Reference Citation Analysis]
610 Tyc-szczepaniak D, Wyrwicz L, Wiśniowska K, Michalski W, Pietrzak L, Bujko K. Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: long-term results of a phase II study. Acta Oncologica 2016;55:1369-70. [DOI: 10.1080/0284186x.2016.1177201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
611 Huang CW, Yeh YS, Su WC, Tsai HL, Choy TK, Huang MY, Huang CM, Wu IC, Hu HM, Hsu WH, Su YC, Wang JY. Robotic surgery with high dissection and low ligation technique for consecutive patients with rectal cancer following preoperative concurrent chemoradiotherapy. Int J Colorectal Dis 2016;31:1169-77. [PMID: 27055659 DOI: 10.1007/s00384-016-2581-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
612 Ostwal V, Kapoor A, Engineer R, Saklani A, deSouza A, Patil P, Arya S, Ankathi SK, Chopra S, Patil M, Jain S, Ramaswamy A. Systemic chemotherapy and short-course radiation in metastatic rectal cancers: A feasible paradigm in unresectable and potentially resectable cancers. South Asian J Cancer 2019;8:92-7. [PMID: 31069186 DOI: 10.4103/sajc.sajc_174_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
613 Yano H, Moran BJ. The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West. Br J Surg. 2008;95:33-49. [PMID: 18165939 DOI: 10.1002/bjs.6061] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 6.5] [Reference Citation Analysis]
614 Patel SA, Ryan DP, Hong TS. Combined Modality Therapy for Rectal Cancer. Cancer J 2016;22:211-7. [PMID: 27341601 DOI: 10.1097/PPO.0000000000000193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
615 Uehara K, Ito Z, Yoshino Y, Arimoto A, Kato T, Nakamura H, Imagama S, Nishida Y, Nagino M. Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer. Eur J Surg Oncol. 2015;41:413-420. [PMID: 25477268 DOI: 10.1016/j.ejso.2014.11.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
616 Ciria JP, Eguiguren M, Cafiero S, Uranga I, Diaz de Cerio I, Querejeta A, Urraca JM, Minguez J, Guimon E, Puertolas JR. Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma? Rep Pract Oncol Radiother 2015;20:1-11. [PMID: 25535578 DOI: 10.1016/j.rpor.2014.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
617 Jin F, Luo H, Zhou J, Wu Y, Sun H, Liu H, Zheng X, Wang Y. Dose-time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer. Ther Adv Med Oncol 2020;12:1758835920907537. [PMID: 32165928 DOI: 10.1177/1758835920907537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
618 Hanna CR, O'Cathail SM, Graham JS, Saunders M, Samuel L, Harrison M, Devlin L, Edwards J, Gaya DR, Kelly CA, Lewsley LA, Maka N, Morrison P, Dinnett L, Dillon S, Gourlay J, Platt JJ, Thomson F, Adams RA, Roxburgh CSD. Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT). Radiat Oncol 2021;16:163. [PMID: 34446053 DOI: 10.1186/s13014-021-01888-1] [Reference Citation Analysis]
619 Yu M, Jang HS, Jeon DM, Cheon GS, Lee HC, Chung MJ, Kim SH, Lee JH. Dosimetric evaluation of Tomotherapy and four-box field conformal radiotherapy in locally advanced rectal cancer. Radiat Oncol J 2013;31:252-9. [PMID: 24501715 DOI: 10.3857/roj.2013.31.4.252] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
620 Chionh F, Lau D, Yeung Y, Price T, Tebbutt N. Oral versus intravenous fluoropyrimidines for colorectal cancer. Cochrane Database Syst Rev 2017;7:CD008398. [PMID: 28752564 DOI: 10.1002/14651858.CD008398.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
621 Fernandes JM, Jandrey EHF, Koyama FC, Leite KRM, Camargo AA, Costa ÉT, Perez RO, Asprino PF. Metformin as an Alternative Radiosensitizing Agent to 5-Fluorouracil During Neoadjuvant Treatment for Rectal Cancer. Dis Colon Rectum 2020;63:918-26. [PMID: 32229782 DOI: 10.1097/DCR.0000000000001626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
622 Huang CY, Wei CC, Chen KC, Chen HJ, Cheng AL, Chen KF. Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A. Cancer Lett. 2012;317:9-15. [PMID: 22085493 DOI: 10.1016/j.canlet.2011.11.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
623 Bujko K, Kolodziejczyk M. The 5×5Gy with delayed surgery in non-resectable rectal cancer: A new treatment option. Radiotherapy and Oncology 2008;87:311-3. [DOI: 10.1016/j.radonc.2007.12.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
624 Beppu N, Kimura F, Aihara T, Doi H, Tomita N, Yanagi H, Yamanaka N. Patterns of Local Recurrence and Oncologic Outcomes in T3 Low Rectal Cancer (≤5 cm from the Anal Verge) Treated With Short-Course Radiotherapy With Delayed Surgery: Outcomes in T3 Low Rectal Cancer Treated With Short-Course Radiotherapy With Delayed Surgery. Ann Surg Oncol 2017;24:219-26. [DOI: 10.1245/s10434-016-5604-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
625 Chapman BC, Goodman K, Hosokawa P, Gleisner A, Cowan ML, Birnbaum E, Vogel JD. Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB: CHAPMAN et al.. J Surg Oncol 2019;119:518-31. [DOI: 10.1002/jso.25355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
626 Palta M, Willett CG, Czito BG. Short-Course versus Long-Course Chemoradiation in Rectal Cancer—Time to Change Strategies? Curr Treat Options in Oncol 2014;15:421-8. [DOI: 10.1007/s11864-014-0296-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
627 Kaytan-Saglam E, Balik E, Saglam S, Akgün Z, Ibis K, Keskin M, Dagoglu N, Kapran Y, Gulluoglu M. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer. J Cancer Res Clin Oncol 2017;143:1597-603. [PMID: 28374169 DOI: 10.1007/s00432-017-2406-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
628 Minsky BD. Short-Course Radiation Versus Long-Course Chemoradiation for Rectal Cancer: Making Progress. JCO 2012;30:3777-8. [DOI: 10.1200/jco.2012.45.0551] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]